Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1P 140----1件: 49 💬
2P-1037----1件: 299 💬
3P-188 NF----1件: 113 💬
4P-552----1件: 53 💬
5P-CD19cd20-ALLO1 cells----1件: 49 💬
6P-MPA concentration----1件: 51 💬
7P144----1件: 51 💬
8P144 cream----1件: 51 💬
9P144 cytokines inhibitors----1件: 51 💬
10P144 digna cream----1件: 51 💬
11P144. cytokines inhibitors----1件: 51 💬
12P28GST----1件: 96 💬
13P2b001----1件: 6 💬
14P2b001 0.6/0.75 MG----1件: 6 💬
15P32/98----1件: 37 💬
16P38 (4) MAP kinase inhibitor----1件: 46 💬
17P38 inhibitor (4) 150MG----1件: 46 💬
18P38 inhibitor (4) 25MG----1件: 46 💬
19P38 inhibitor (4) 300MG----1件: 46 💬
20P38 inhibitor (4) 50MG----1件: 46 💬
21P38 inhibitor (4) 75MG----1件: 46 💬
22P38 MAP kinase inhibitor----1件: 46 💬
23P38(4) MAP kinase inhibitor----1件: 46 💬
24PA101----1件: 85 💬
25PAAG15----1件: 299 💬
26Pabinafusp alfa1件: Pabinafusp alfa1件: Pabinafusp alfa 💬 2件: IDS,
TFRC 💬 		9件: Endocytosis, Ferroptosis, Glycosaminoglycan degradation, HIF-1 signaling pathway, Hematopoietic cell lineage, Lysosome, Phagosome, TGF-beta signaling pathway, Virion - Lassa virus and SFTS virus 💬1件: 19 💬
27Packing----1件: 227 💬
28Paclitaxel1件: Paclitaxel1件: Paclitaxel 💬 9件: TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB 💬 		11件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬1件: 85 💬
29Pacritinib1件: Pacritinib1件: Pacritinib 💬 2件: FLT3,
JAK2 💬 		31件: AGE-RAGE signaling pathway in diabetic complications, Acute myeloid leukemia, Adipocytokine signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Efferocytosis, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Hormone signaling, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Necroptosis, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Prolactin signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis 💬1件: 331 💬
30Padsevonil1件: Padsevonil1件: Padsevonil 💬 3件: SV2,
SV2,
SV2 💬 		1件: ECM-receptor interaction 💬1件: 149 💬
31PAH----1件: 86 💬
32PAH medication----1件: 86 💬
33Pain----1件: 13 💬
34Pain questionnaires----1件: 97 💬
35PALI-2108----1件: 97 💬
36Palifermin1件: Palifermin1件: Palifermin 💬 1件: FGFR2 💬 12件: Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, Gastric cancer, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells 💬6件: 13, 36, 38, 39, 65, 96 💬
37Palliative care----6件: 19, 65, 121, 160, 308, 326 💬
38Palmitoleic acid1件: Palmitoleic Acid---1件: 97 💬
39Palmitoylethanolamide1件: Palmidrol1件: Palmidrol 💬 --1件: 2 💬
40Palopegteriparatide1件: Palopegteriparatide1件: Palopegteriparatide 💬 1件: PTH1R 💬 4件: Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235 💬
41Palovarotene1件: Palovarotene1件: Palovarotene 💬 --1件: 272 💬
42Palovarotene - 1.5MG1件: Palovarotene1件: Palovarotene 💬 --1件: 272 💬
43Palovarotene - 10 MG1件: Palovarotene1件: Palovarotene 💬 --1件: 272 💬
44Palovarotene - 1MG1件: Palovarotene1件: Palovarotene 💬 --1件: 272 💬
45Palovarotene - 2 MG1件: Palovarotene1件: Palovarotene 💬 --1件: 272 💬
46Palovarotene - 2.5 MG1件: Palovarotene1件: Palovarotene 💬 --1件: 272 💬
47Palovarotene - 3 MG1件: Palovarotene1件: Palovarotene 💬 --1件: 272 💬
48Palovarotene - 4 MG1件: Palovarotene1件: Palovarotene 💬 --1件: 272 💬
49Palovarotene - 5 MG1件: Palovarotene1件: Palovarotene 💬 --1件: 272 💬
50Palovarotene 1.5 MG1件: Palovarotene1件: Palovarotene 💬 --1件: 272 💬
51Palovarotene dose level 11件: Palovarotene1件: Palovarotene 💬 --1件: 272 💬
52Palovarotene dose level 21件: Palovarotene1件: Palovarotene 💬 --1件: 272 💬
53Palovarotene dose level 31件: Palovarotene1件: Palovarotene 💬 --1件: 272 💬
54Palovarotene dose level 41件: Palovarotene1件: Palovarotene 💬 --1件: 272 💬
55Palovarotene-2 MG1件: Palovarotene1件: Palovarotene 💬 --1件: 272 💬
56Palovarotene-3 MG1件: Palovarotene1件: Palovarotene 💬 --1件: 272 💬
57Palovarotene-4 MG1件: Palovarotene1件: Palovarotene 💬 --1件: 272 💬
58Paltusotine1件: Paltusotine1件: Paltusotine 💬 1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
59Paltusotine (free base)1件: Paltusotine1件: Paltusotine 💬 1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
60Palynziq1件: Pegvaliase1件: Pegvaliase 💬 1件: phhA 💬 3件: Folate biosynthesis, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬1件: 240 💬
61Pamidronate1件: Pamidronic acid2件: Pamidronate disodium ,
Pamidronic acid 💬 		1件: FDPS 💬 3件: Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬3件: 270, 271, 274 💬
62Pamrevlumab1件: Pamrevlumab1件: Pamrevlumab 💬 1件: CTGF 💬 2件: Apelin signaling pathway, Hippo signaling pathway 💬2件: 85, 113 💬
63Panax quinquefolius1件: Panax quinquefolius whole---1件: 46 💬
64Pancreas powder----1件: 299 💬
65Pancrease MT----1件: 299 💬
66Pancrease MT 10.5, or MT 21----1件: 299 💬
67Pancreaslipase----1件: 299 💬
68Pancreatic enzymes----1件: 298 💬
69Pancreatin1件: Pancrelipase2件: Pancreatin ,
Pancrelipase 💬 		--3件: 96, 298, 299 💬
70Pancreatina----1件: 299 💬
71Pancreatina (Páncreas polvo----1件: 299 💬
72Pancreaze----1件: 299 💬
73Pancrelipase2件: Pancrelipase,
Pancrelipase amylase		2件: Pancreatin ,
Pancrelipase 💬 		--4件: 96, 97, 298, 299 💬
74Pancrelipase amylase2件: Pancrelipase,
Pancrelipase amylase		2件: Pancreatin ,
Pancrelipase 💬 		--1件: 299 💬
75Pancrelipase delayed release1件: Pancrelipase2件: Pancreatin ,
Pancrelipase 💬 		--1件: 299 💬
76Pancrelipase delayed release capsule1件: Pancrelipase2件: Pancreatin ,
Pancrelipase 💬 		--2件: 298, 299 💬
77Pancrelipase microtablets1件: Pancrelipase2件: Pancreatin ,
Pancrelipase 💬 		--1件: 299 💬
78Pancrelipase with bicarbonate1件: Pancrelipase2件: Pancreatin ,
Pancrelipase 💬 		--1件: 299 💬
79Pancrelipase/pancreas powder1件: Pancrelipase2件: Pancreatin ,
Pancrelipase 💬 		--2件: 298, 299 💬
80Panhematin----1件: 254 💬
81Pankreatin----1件: 299 💬
82Pantethine1件: Pantethine1件: Pantethine 💬 --1件: 121 💬
83Pantoprazole1件: Pantoprazole2件: Pantoprazole sodium ,
Pantoprazole 💬 		2件: ATP4A,
ATP4B 💬 		3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬2件: 13, 65 💬
84Pantoprazolo 20 MG gastro-resistant tablets----1件: 65 💬
85Panzyga----1件: 14 💬
86Panzytrat----1件: 298 💬
87Panzytrat 25.000----1件: 298 💬
88Panzytrat 25.000 FIP-E units OF lipase----1件: 298 💬
89Panzytrat 25000----1件: 299 💬
90Panzytrat® 25,000----1件: 299 💬
91Panzytrat® OK----1件: 299 💬
92Paquinimod1件: Paquinimod---2件: 49, 51 💬
93Paracetamol1件: Acetaminophen1件: Acetaminophen 💬 2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬4件: 3, 6, 13, 46 💬
94Paracetamol 120MG/5ML oral suspension1件: Acetaminophen1件: Acetaminophen 💬 2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 3 💬
95Paracetamolo----7件: 2, 11, 14, 28, 61, 63, 309 💬
96Paracetamolo 500 MG----1件: 13 💬
97Paracetamolo DOC generici - 1000 MG compressa 16 compresse----1件: 19 💬
98Paracetamolo nova argentia - 500 MG compresse 20 compresse----1件: 300 💬
99Paraclisib----1件: 61 💬
100Paraffin OIL1件: Mineral oil1件: Mineral oil 💬 --1件: 291 💬
101Paralen 500----1件: 46 💬
102Parapres----1件: 6 💬
103Parathyroid allotransplant----1件: 235 💬
104Parathyroid hormon 1-84----1件: 235 💬
105Parathyroid hormone1件: Parathyroid hormone1件: Parathyroid hormone 💬 2件: PTH1R,
PTHR2 💬 		4件: Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬2件: 70, 235 💬
106Parathyroid hormone (1-84) human recombinant1件: Parathyroid hormone1件: Parathyroid hormone 💬 2件: PTH1R,
PTHR2 💬 		4件: Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235 💬
107Parathyroideahormon----1件: 235 💬
108Parcopa2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
109Pardaprunox----1件: 6 💬
110Pardoprunox1件: Pardoprunox2件: Pardoprunox hydrochloride ,
Pardoprunox 💬 		3件: DRD2,
DRD3,
HTR1 💬 		12件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬1件: 6 💬
111Pardoprunox hydrochloride1件: Pardoprunox2件: Pardoprunox hydrochloride ,
Pardoprunox 💬 		3件: DRD2,
DRD3,
HTR1 💬 		12件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬1件: 6 💬
112Parecoxib1件: Parecoxib3件: Valdecoxib ,
Parecoxib ,
Parecoxib sodium 💬 		1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬2件: 46, 271 💬
113Parenteral remodulin (treprostinil) injection----1件: 86 💬
114Parenteral treprostinil----1件: 86 💬
115Pari eflow nebulizer system----2件: 229, 299 💬
116Paricalcitol1件: Paricalcitol1件: Paricalcitol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬5件: 19, 66, 218, 238, 298 💬
117Parkinson mpower mobile application----1件: 6 💬
118Parnaparin sodium1件: Parnaparin---1件: 97 💬
119Paroxetine1件: Paroxetine4件: Paroxetine hydrochloride hemihydrate ,
Paroxetine ,
Paroxetine hydrochloride ,
Paroxetine mesylate 💬 		1件: SLC6A4 💬 3件: Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬4件: 6, 13, 46, 85 💬
120Paroxetine & prednisolone2件: Paroxetine,
Prednisolone		5件: Prednisolone ,
Paroxetine hydrochloride hemihydrate ,
Paroxetine ,
Paroxetine hydrochloride ,
Paroxetine mesylate 💬 		2件: NR3C1,
SLC6A4 💬 		4件: Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 46 💬
121Paroxetine hydrochloride 10 & 20 MG and prednisolone 1 MG BP1件: Paroxetine4件: Paroxetine hydrochloride hemihydrate ,
Paroxetine ,
Paroxetine hydrochloride ,
Paroxetine mesylate 💬 		1件: SLC6A4 💬 3件: Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 46 💬
122Paroxetine hydrochloride tablets 10 & 20 MG and prednisolone 1 MG BP1件: Paroxetine4件: Paroxetine hydrochloride hemihydrate ,
Paroxetine ,
Paroxetine hydrochloride ,
Paroxetine mesylate 💬 		1件: SLC6A4 💬 3件: Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 46 💬
123Parsaclisib1件: Parsaclisib1件: Parsaclisib 💬 1件: PIK3CA_B_D 💬 103件: AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬3件: 35, 53, 61 💬
124Parsaclisinib----1件: 61 💬
125Part 1 levulan injection----1件: 34 💬
126Part 1 levulan surface application twice with microneedling----1件: 34 💬
127Part 1, JM-010 component group A----1件: 6 💬
128Part 1, JM-010 component group B----1件: 6 💬
129Part 1, JM-010 component group C----1件: 6 💬
130Part 1: LJN452----1件: 93 💬
131Part 2, JM-010 combination group A----1件: 6 💬
132Part 2, JM-010 combination group B----1件: 6 💬
133Part 2, JM-010 component group C----1件: 6 💬
134Part 2: LJN452 dose level 1----1件: 93 💬
135Part 2: LJN452 dose level 2----1件: 93 💬
136Part A----1件: 46 💬
137Part A: 100 MG/ML GSK2618960----1件: 13 💬
138Part B----1件: 46 💬
139Part B OPEN-label extension----1件: 51 💬
140Part B: dose OF GSK2618960 decided from part A----1件: 13 💬
141Part C: dose OF GSK2618960 decided from part A and B----1件: 13 💬
142Part I - etoricoxib 60 MG1件: Etoricoxib1件: Etoricoxib 💬 1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271 💬
143Part I - etoricoxib 90 MG1件: Etoricoxib1件: Etoricoxib 💬 1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271 💬
144Part I- naproxen 1000 MG1件: Naproxen2件: Naproxen ,
Naproxen sodium 💬 		2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271 💬
145Part II- etoricoxib 60 MG1件: Etoricoxib1件: Etoricoxib 💬 1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271 💬
146Part II- etoricoxib 90 MG1件: Etoricoxib1件: Etoricoxib 💬 1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271 💬
147Part II- naproxen 1000 MG1件: Naproxen2件: Naproxen ,
Naproxen sodium 💬 		2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271 💬
148Partial enteral nutrition----3件: 96, 97, 271 💬
149Participant OPEN-response writing----1件: 6 💬
150Participant SELF-assessment surveys----1件: 6 💬
151PAS-004 tablets1件: PAS-004---1件: 34 💬
152Pasireotida1件: Pasireotide3件: Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬 		4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
153Pasireotida 3001件: Pasireotide3件: Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬 		4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75 💬
154Pasireotida 6001件: Pasireotide3件: Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬 		4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75 💬
155Pasireotida 9001件: Pasireotide3件: Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬 		4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75 💬
156Pasireotide1件: Pasireotide3件: Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬 		4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬3件: 74, 75, 77 💬
157Pasireotide 0.3MG1件: Pasireotide3件: Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬 		4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75 💬
158Pasireotide 0.6 MG/ML1件: Pasireotide3件: Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬 		4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75 💬
159Pasireotide 0.6MG1件: Pasireotide3件: Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬 		4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75 💬
160Pasireotide 0.9 MG1件: Pasireotide3件: Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬 		4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75 💬
161Pasireotide 20MG1件: Pasireotide3件: Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬 		4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬2件: 75, 77 💬
162Pasireotide 40MG1件: Pasireotide3件: Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬 		4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬2件: 75, 77 💬
163Pasireotide 60MG1件: Pasireotide3件: Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬 		4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬2件: 75, 77 💬
164Pasireotide diaspartate1件: Pasireotide3件: Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬 		4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬2件: 75, 77 💬
165Pasireotide LAR1件: Pasireotide3件: Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬 		4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬3件: 67, 75, 77 💬
166Pasireotide LAR 60 MG1件: Pasireotide3件: Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬 		4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
167Pasireotide long acting release formulation1件: Pasireotide3件: Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬 		4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
168Pasireotide pamoate1件: Pasireotide3件: Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬 		4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬2件: 75, 77 💬
169Pasireotide SUB-cutaneous1件: Pasireotide3件: Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬 		4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75 💬
170Pasireotide with or without cabergoline1件: Pasireotide3件: Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬 		4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75 💬
171Pasireotode----1件: 75 💬
172Passive LEG raising----1件: 86 💬
173Passive stretching----1件: 121 💬
174PAT----1件: 160 💬
175Patient current care----1件: 46 💬
176Patient treated with dmard----1件: 46 💬
177Patients will BE randomized TO receive EHP-101----1件: 51 💬
178Patients' existing NON-steroidal ANTI-inflammatory drug (nsaid) AT approved doses----1件: 46 💬
179Patisiran1件: Patisiran2件: Patisiran sodium ,
Patisiran 💬 		1件: TTR 💬 1件: Thyroid hormone synthesis 💬1件: 28 💬
180Pazopanib1件: Pazopanib1件: Pazopanib hydrochloride 💬 6件: FLT1,
FLT4,
KDR,
KIT,
PDGFRA,
PDGFRB 💬 		30件: Acute myeloid leukemia, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Glioma, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬1件: 227 💬
181PB006----1件: 13 💬
182PB1046 injection----1件: 113 💬
183PB1046 subcutaneous injection----1件: 86 💬
184PB1046, VIP-ELP1-120, vasomera1件: Vasomera---1件: 86 💬
185PBF-509----1件: 6 💬
186PBF-677----1件: 97 💬
187PBF-999----1件: 8 💬
188PBF-999 / 160 MG----1件: 8 💬
189PBF-999 / 320 MG----1件: 8 💬
190PBFT021件: PBFT02---1件: 127 💬
191PBGM011件: PBGM01---1件: 19 💬
192PBI4050----2件: 85, 299 💬
193PBKR031件: PBKR03---1件: 19 💬
194Pbmc autotransplantation----1件: 2 💬
195PBO----1件: 50 💬
196PBT2----1件: 8 💬
197PBT434, 5,7-dichloro-2-((ethylamino)methyl)-8-hydroxy-3-methylquinazolin-4(3H)-ONE mesylate----1件: 17 💬
198PC945----1件: 299 💬
199PCA----3件: 6, 46, 60 💬
200Pcclchimgp91S lentiviral vector transduced CD34+ cells infusion----1件: 65 💬
201Pcdai----1件: 96 💬
202PCO371----1件: 235 💬
203PCR polymorphism----1件: 46 💬
204PCR-rflp----1件: 97 💬
205PCV----1件: 13 💬
206PD 0299685----1件: 226 💬
207PD 0299685 AT 15MG BID----1件: 226 💬
208PD 0299685 AT 30MG BID----1件: 226 💬
209PD 0360324----2件: 46, 84 💬
210PD exercise intervention----1件: 6 💬
211PD patients H&Y=1.5-2 medications OFF----1件: 6 💬
212PD patients H&Y=1.5-2 medications ON----1件: 6 💬
213PD patients H&Y=3 medications OFF----1件: 6 💬
214PD patients H&Y=3 medications ON----1件: 6 💬
215PD vitamin + exercise----1件: 6 💬
216PD vitamin supplementation----1件: 6 💬
217PD-02996851件: PD-0299685---1件: 226 💬
218PD-03259011件: Mirdametinib1件: Mirdametinib 💬 2件: MAP2K1,
MAP2K2 💬 		88件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, Efferocytosis, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 34 💬
219PD-RBD----1件: 6 💬
220PD00377 NA-salt----1件: 85 💬
221PDA001----2件: 46, 96 💬
222PDE5 inhibitor----1件: 86 💬
223PDM608----1件: 6 💬
224PEA-LUT----1件: 127 💬
225Peak----1件: 13 💬
226Peanut butter1件: Peanut---1件: 13 💬
227Pectin1件: Pectin1件: Pectin 💬 --1件: 96 💬
228Pednisone----2件: 43, 44 💬
229Peficitinib1件: Peficitinib1件: Peficitinib 💬 3件: JAK1,
JAK2,
JAK3 💬 		39件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
230PEG----8件: 6, 13, 41, 46, 76, 97, 246, 337 💬
231PEG LOW volume with bisacodyl----1件: 97 💬
232PEG tube----1件: 6 💬
233PEG-ADA----1件: 65 💬
234PEG-interferon ALFA-2B----1件: 26 💬
235PEG-interferon alpha-2B----1件: 34 💬
236PEG-interleukin-21件: PEG-interleukin-2---1件: 65 💬
237PEG-liposomal prednisolone sodium phosphate2件: Phosphate ion,
Prednisolone		1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 13, 97 💬
238PEG-RHG-CSF----1件: 60 💬
239Pegcetacoplam----1件: 2 💬
240Pegcetacoplan1件: Pegcetacoplan1件: Pegcetacoplan 💬 1件: C3 💬 17件: Alcoholic liver disease, Chagas disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Phagosome, Shigellosis, Staphylococcus aureus infection, Systemic lupus erythematosus, Tuberculosis, Viral carcinogenesis 💬4件: 2, 61, 62, 222 💬
241Pegfilgrastim1件: Pegfilgrastim1件: Pegfilgrastim 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 60 💬
242Peginesatide1件: Peginesatide2件: Peginesatide ,
Peginesatide acetate 💬 		1件: EPOR 💬 7件: Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 283 💬
243Peginterferon ALFA-2A 180 MCG/ML injectable solution1件: Peginterferon alfa-2a1件: Peginterferon alfa-2a 💬 2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 222 💬
244Peginterferon BETA-1A1件: Peginterferon beta-1a1件: Peginterferon beta-1a 💬 2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
245Peginterferone beta 1A----1件: 13 💬
246Peginterferone BETA-1A----1件: 13 💬
247Peginterferone lambda-1A----1件: 13 💬
248Pegsunercept1件: Pegsunercept1件: Pegsunercept 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
249Pegtarviliase IV1件: Pegtarviliase---1件: 337 💬
250Pegtarviliase SC1件: Pegtarviliase---1件: 337 💬
251Pegtibatinase1件: Pegtibatinase1件: Pegtibatinase 💬 1件: CBS 💬 3件: Cysteine and methionine metabolism, Glycine, serine and threonine metabolism, One carbon pool by folate 💬1件: 337 💬
252Pegunigalsidase alfa1件: Pegunigalsidase alfa1件: Pegunigalsidase alfa 💬 1件: GLA 💬 5件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬1件: 19 💬
253Pegunigalsidase alpha----1件: 19 💬
254Pegunigalsidase-alfa----1件: 19 💬
255Pegvaliase1件: Pegvaliase1件: Pegvaliase 💬 1件: phhA 💬 3件: Folate biosynthesis, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬1件: 240 💬
256Pegvaliase-pqpz1件: Pegvaliase1件: Pegvaliase 💬 1件: phhA 💬 3件: Folate biosynthesis, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬1件: 240 💬
257Pegvisomant1件: Pegvisomant1件: Pegvisomant 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬2件: 77, 265 💬
258Pegvisomant treatment1件: Pegvisomant1件: Pegvisomant 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 77 💬
259Pegvisomant/ sandostatin LAR1件: Pegvisomant1件: Pegvisomant 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 77 💬
260Pegylated intereron BETA-1A----1件: 13 💬
261Pegylated interferon alfa----1件: 96 💬
262Pegylated interferon alpha2B----1件: 227 💬
263Pegylated interferon BETA-1A2件: Human interferon beta,
Interferon beta-1a		2件: Interferon beta ,
Interferon beta-1a 💬 		2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
264Pegylated recombinant human hyaluronidase PH202件: Hyaluronidase (human recombinant),
Pegvorhyaluronidase alfa		2件: Hyaluronidase ,
Pegvorhyaluronidase alfa 💬 		--1件: 28 💬
265Pelubiprofen 30 MG1件: Pelubiprofen1件: Pelubiprofen 💬 --1件: 46 💬
266Pelvic floor muscle exercise-based behavioral therapy----1件: 6 💬
267Pelvic floor physical therapy----1件: 226 💬
268Pemafibrate1件: Pemafibrate1件: Pemafibrate 💬 1件: NR1C1 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
269Pembrolizumab1件: Pembrolizumab1件: Pembrolizumab 💬 1件: PDCD1 💬 3件: Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬2件: 25, 285 💬
270Pembrolizumab, 25 MG/ML solution FOR intravenous (IV) injection1件: Pembrolizumab1件: Pembrolizumab 💬 1件: PDCD1 💬 3件: Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬1件: 25 💬
271Pemine - 150 MG capsule rigide 50 capsule----1件: 171 💬
272Pemirolast1件: Pemirolast2件: Pemirolast potassium ,
Pemirolast 💬 		--1件: 113 💬
273Pemziviptadil (PB1046) injection1件: Vasomera---1件: 86 💬
274Pending----7件: 6, 13, 19, 96, 97, 113, 302 💬
275Penicillamine1件: Penicillamine1件: Penicillamine 💬 --2件: 51, 171 💬
276Pentamidina isetionato1件: Pentamidine2件: Pentamidine isethionate ,
Pentamidine 💬 		--1件: 61 💬
277Pentamidine1件: Pentamidine2件: Pentamidine isethionate ,
Pentamidine 💬 		--1件: 61 💬
278Pentasa1件: Mesalazine1件: Mesalamine 💬 --2件: 96, 97 💬
279Pentasa 500 MG retardtabletten1件: Mesalazine1件: Mesalamine 💬 --1件: 97 💬
280Pentasa compact 2G, granulate with prolonged release1件: Mesalazine1件: Mesalamine 💬 --1件: 97 💬
281Pentasa compact 4G, granulate with prolonged release1件: Mesalazine1件: Mesalamine 💬 --1件: 97 💬
282Pentasa enema1件: Mesalazine1件: Mesalamine 💬 --1件: 97 💬
283Pentasa prolonged release granules 2G1件: Mesalazine1件: Mesalamine 💬 --1件: 97 💬
284Pentasa sachet1件: Mesalazine1件: Mesalamine 💬 --2件: 96, 97 💬
285Pentasa sachet 1 G1件: Mesalazine1件: Mesalamine 💬 --1件: 97 💬
286Pentasa sachet 1 G prolonged release granules1件: Mesalazine1件: Mesalamine 💬 --1件: 96 💬
287Pentasa sachet 1G1件: Mesalazine1件: Mesalamine 💬 --1件: 97 💬
288Pentasa sachet 2 G1件: Mesalazine1件: Mesalamine 💬 --1件: 97 💬
289Pentetreotide1件: Pentetreotide1件: Pentetreotide 💬 --1件: 75 💬
290Pentosan polysulfat SP 54® injection solution----1件: 19 💬
291Pentosan polysulfate1件: Pentosan polysulfate1件: Pentosan polysulfate sodium 💬 --1件: 26 💬
292Pentosan polysulfate sodium1件: Pentosan polysulfate1件: Pentosan polysulfate sodium 💬 --1件: 19 💬
293Pentosan polysulfate sodium 100 MG1件: Pentosan polysulfate1件: Pentosan polysulfate sodium 💬 --1件: 226 💬
294Pentosan polysulphate SP54----1件: 19 💬
295Pentostatin1件: Pentostatin1件: Pentostatin 💬 1件: add 💬 2件: Primary immunodeficiency, Purine metabolism 💬1件: 60 💬
296Pentoxifylline1件: Pentoxifylline1件: Pentoxifylline 💬 --11件: 26, 56, 84, 93, 96, 97, 113, 220, 222, 296, 298 💬
297Pentoxifylline 400 MG1件: Pentoxifylline1件: Pentoxifylline 💬 --2件: 6, 97 💬
298Peptid coupled RED blood cells----1件: 13 💬
299Peptide coupled RED blood cells----1件: 13 💬
300Peptide-conjugated phosphorodiamidate morpholino oligomer FOR exon 51 skipping----1件: 113 💬
301Peptide-conjugated phosphorodiamide morpholino oligomer FOR exon 51 skipping----1件: 113 💬
302Peptidic+probiotic----1件: 96 💬
303Peptison liquid----1件: 96 💬
304Perampanel1件: Perampanel2件: Perampanel ,
Perampanel hydrate 💬 		4件: GRIA1,
GRIA2,
GRIA3,
GRIA4 💬 		17件: Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway 💬3件: 2, 6, 144 💬
305Percutaneous endoscopic gastrostomy tube----1件: 6 💬
306Percutaneous endoscopic gastrostomy with A jejunal (PEG-J) tube----1件: 6 💬
307Percutaneous lumbar decompression----1件: 70 💬
308Percutaneous sirolimus----1件: 278 💬
309Perdix----1件: 19 💬
310Peresolimab1件: Peresolimab1件: Peresolimab 💬 1件: PDCD1 💬 3件: Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬1件: 46 💬
311Perfalgan----1件: 2 💬
312Perflubutane1件: Perflubutane1件: Perflubutane 💬 --2件: 298, 300 💬
313Perfluorinated GAS/oxygen mixture----1件: 299 💬
314Perfluoropropane1件: Perflutren1件: Perflutren 💬 --1件: 299 💬
315Perform blood cells and fibroblasts biochemical and immuno-labeled investigations----1件: 265 💬
316Perfusion OF treatment ocrelizumab----1件: 13 💬
317Perfusion OF treatment rituximab----1件: 13 💬
318Pergolide1件: Pergolide2件: Pergolide mesylate ,
Pergolide 💬 		2件: DRD1,
DRD2 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
319Perhexiline1件: Perhexiline2件: Perhexiline maleate ,
Perhexiline 💬 		8件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S,
CPT1A,
CPT1B,
CPT1C,
CPT2 💬 		47件: AMPK signaling pathway, Adipocytokine signaling pathway, Adrenergic signaling in cardiomyocytes, Alcoholic liver disease, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Dopaminergic synapse, Efferocytosis, Fatty acid degradation, GABAergic synapse, Glucagon signaling pathway, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin resistance, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, PPAR signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Thermogenesis, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 58, 272 💬
320PERI-neural dexamethasone 1 MG----1件: 46 💬
321Perindopril1件: Perindopril3件: Perindopril erbumine ,
Perindopril ,
Perindopril arginine 💬 		1件: ACE 💬 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬3件: 113, 167, 222 💬
322Perindopril 2MG tablets1件: Perindopril3件: Perindopril erbumine ,
Perindopril ,
Perindopril arginine 💬 		1件: ACE 💬 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬1件: 113 💬
323Perindopril arginina1件: Perindopril3件: Perindopril erbumine ,
Perindopril ,
Perindopril arginine 💬 		1件: ACE 💬 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬1件: 58 💬
324Perindopril arginine1件: Perindopril3件: Perindopril erbumine ,
Perindopril ,
Perindopril arginine 💬 		1件: ACE 💬 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬1件: 58 💬
325Period 1 IBI112 dose 1----1件: 97 💬
326Period 1 IBI112 dose 2----1件: 97 💬
327Period 2 IBI112 dose 3----1件: 97 💬
328Period 2 IBI112 dose 4----1件: 97 💬
329Periodized exercise training----1件: 13 💬
330Periodontitis-associated bacteria presence----1件: 46 💬
331Peripheral blood stem cell----1件: 285 💬
332Peripheral blood stem cell infusion----1件: 96 💬
333Peripheral blood stem cell transplantation----12件: 11, 13, 14, 28, 51, 60, 62, 65, 283, 284, 285, 286 💬
334Peripheral blood stem cells----4件: 51, 60, 62, 65 💬
335Peripheral blood withdrawal----1件: 13 💬
336Permitted dmards----1件: 46 💬
337Persantin 100 MG and----1件: 46 💬
338Personalized ayurveda treatment protocol----1件: 46 💬
339Personalized B-fructan diet----1件: 97 💬
340Personalized extended interval dosing OF natalizumab----1件: 13 💬
341Personalized pectin diet----1件: 97 💬
342Pertussis filamentous haemagglutinin adsorbed ON aluminium hydroxide----1件: 46 💬
343Pertussis pertactin adsorbed ON aluminium hydroxide----1件: 46 💬
344Pertussis toxoid adsorbed ON aluminium hydroxide1件: Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)---1件: 46 💬
345Pertussis vaccine1件: Pertussis vaccine1件: Pertussis vaccine 💬 --1件: 46 💬
346Pertzye----1件: 299 💬
347Perxexiline----1件: 58 💬
348PET (positron emission tomography) study----1件: 17 💬
349PET imaging----1件: 85 💬
350PET with 11C-flumazenil----1件: 13 💬
351PET with [11C]flumazenil----1件: 13 💬
352PET-CT----1件: 40 💬
353PET-CT imaging with [89ZR]-bevacizumab----1件: 86 💬
354PET/CT----4件: 5, 6, 7, 127 💬
355PET/CT scan----2件: 13, 67 💬
356PET/CT scan: TWO PET scans using 1. C-11 HED and 2. N-13 ammonia or rubidium-82----1件: 86 💬
357PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714----1件: 85 💬
358PET/MR with [11C]PBR28----1件: 6 💬
359PET10----1件: 41 💬
360PET3----1件: 41 💬
361Pethidine1件: Meperidine2件: Meperidine hydrochloride ,
Pethidine 💬 		1件: OPRM1 💬 5件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬2件: 97, 298 💬
362Petrolatum1件: Petrolatum2件: Petrolatum, white ,
Petrolatum 💬 		--1件: 158 💬
363Pexsig----1件: 58 💬
364PF 06687234----2件: 96, 97 💬
365PF-004897911件: PF-00489791---1件: 86 💬
366PF-00547659----2件: 96, 97 💬
367PF-00547659 SC injection----2件: 96, 97 💬
368PF-02545920----1件: 8 💬
369PF-04171327----1件: 46 💬
370PF-04171327 10 MG----1件: 46 💬
371PF-04171327 25 MG----1件: 46 💬
372PF-04236921----2件: 49, 96 💬
373PF-04236921 SC injection----1件: 96 💬
374PF-04383119----1件: 226 💬
375PF-05208763----1件: 67 💬
376PF-05230917----1件: 97 💬
377PF-05280586----1件: 46 💬
378PF-05285401----1件: 97 💬
379PF-062526161件: Domagrozumab1件: Domagrozumab 💬 1件: MSTN 💬 1件: Cytokine-cytokine receptor interaction 💬1件: 113 💬
380PF-06291826-83/FX-1006A----1件: 28 💬
381PF-06342674 0.25 MG/KG----1件: 13 💬
382PF-06342674 1.5 MG/KG----1件: 13 💬
383PF-06342674 6.0 MG/KG----1件: 13 💬
384PF-06410293----1件: 46 💬
385PF-06412562----1件: 6 💬
386PF-06438179----1件: 46 💬
387PF-06462700----1件: 60 💬
388PF-06480605----1件: 97 💬
389PF-06480605 100 MG/ML----1件: 97 💬
390PF-066497511件: Tavapadon1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		12件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
391PF-06649751 - 15MG1件: Tavapadon1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		12件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
392PF-06649751 - 1MG1件: Tavapadon1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		12件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
393PF-06649751 - 5MG1件: Tavapadon1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		12件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
394PF-066508331件: PF-06650833---1件: 46 💬
395PF-06650833 100 MG1件: PF-06650833---1件: 46 💬
396PF-06650833 20 MG1件: PF-06650833---1件: 46 💬
397PF-06651600----3件: 46, 96, 97 💬
398PF-06651600 10 MG----1件: 97 💬
399PF-06651600 50 MG----2件: 96, 97 💬
400PF-06651600 50MG----1件: 96 💬
401PF-06651600-15----2件: 96, 97 💬
402PF-06669571----1件: 6 💬
403PF-06687234----1件: 97 💬
404PF-067008411件: PF-06700841---1件: 96 💬
405PF-06700841 15 MG1件: PF-06700841---1件: 49 💬
406PF-06700841 25 MG1件: PF-06700841---2件: 96, 97 💬
407PF-06700841 25MG1件: PF-06700841---1件: 49 💬
408PF-06700841 30 MG1件: PF-06700841---1件: 49 💬
409PF-06700841 45 MG1件: PF-06700841---1件: 49 💬
410PF-06700841 5 MG1件: PF-06700841---2件: 96, 97 💬
411PF-06700841 5MG1件: PF-06700841---1件: 49 💬
412PF-06700841-151件: PF-06700841---3件: 49, 96, 97 💬
413PF-06730512----1件: 222 💬
414PF-06755347 intravenous healthy participant----1件: 63 💬
415PF-06755347 subcutaneous healthy participant----1件: 63 💬
416PF-06755347 subcutaneous ITP----1件: 63 💬
417PF-06823859----1件: 50 💬
418PF-06823859 high----1件: 50 💬
419PF-06823859 LOW----1件: 50 💬
420PF-06826647----1件: 97 💬
421PF-06826647 100 MG QD----1件: 97 💬
422PF-06826647 300 MG QD----1件: 97 💬
423PF-06826647 600 MG QD----1件: 97 💬
424PF-06835375----3件: 46, 49, 63 💬
425PF-06939926----1件: 113 💬
426PF-07054894----1件: 97 💬
427PF-07256472----1件: 276 💬
428PF-07868489----1件: 86 💬
429PF-6826647 400 MG QD----1件: 97 💬
430PF2020-cell (UC-mscs) - allogeneic human umbilical cord mesenchymal stem cells----1件: 96 💬
431Pfefferminzblätter 1ML/10ML----1件: 97 💬
432Pfizer comirnaty vaccine----1件: 97 💬
433PFP----1件: 299 💬
434PFP and SF6 human lung coil----1件: 299 💬
435PFT----1件: 89 💬
436PG-760564----1件: 46 💬
437PG2----1件: 63 💬
438PG203----1件: 6 💬
439PGM169/GL67A----1件: 299 💬
440PGN-EDO51----1件: 113 💬
441PGN-edodm1----1件: 113 💬
442PGN-edodm1 FOR infusion----1件: 113 💬
443PGT-1 gene lipid complex----1件: 299 💬
444PGX-guided POST-operative pain management----2件: 96, 97 💬
445PGZ BED----1件: 21 💬
446PH-7978041件: PH-797804---1件: 46 💬
447PHA-022121----1件: 65 💬
448PHA-022121 monohydrate----1件: 65 💬
449Phagocyte oxidase subunit transduced CD34 hematopoietic stem cells----1件: 65 💬
450Pharmacodynamics----1件: 34 💬
451Pharmacogenomic study----1件: 26 💬
452Pharmacokinetic analysis----1件: 49 💬
453Pharmacokinetics OF certolizumab pegol----2件: 46, 96 💬
454Pharmacokinetics study----1件: 50 💬
455Pharmacologic approaches TO glycemic treatment----1件: 298 💬
456Pharmacological study----7件: 28, 34, 62, 74, 89, 232, 331 💬
457Phase 1, SQY51----1件: 113 💬
458Phase 1: conventiaonal dmard----1件: 46 💬
459Phase 1: etanercept----1件: 46 💬
460Phase 1: methotrexate----1件: 46 💬
461Phase 2----1件: 13 💬
462Phase 2. continous/bilevel positive airway presure with additional oxygen support BY devilbiss 525 KS oxygen concentrator----1件: 230 💬
463Phase 2: optional ETN, SSZ, HCQ, MTX----1件: 46 💬
464Phase 3----1件: 13 💬
465Phase1 : cded/modulen™IBD® + maintenance therapy----1件: 96 💬
466PHE----2件: 75, 77 💬
467Pheburane----1件: 21 💬
468Phenlarmide tablets----1件: 6 💬
469Phenoptin----2件: 124, 240 💬
470Phenothiazine1件: Phenothiazine1件: Phenothiazine 💬 --1件: 127 💬
471Phenserine1件: Phenserine---1件: 6 💬
472Phentermine-topiramate1件: Phentermine2件: Phentermine ,
Phentermine hydrochloride 💬 		5件: MAO,
MAO,
SLC6A2,
SLC6A3,
SLC6A4 💬 		16件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Phenylalanine metabolism, Serotonergic synapse, Synaptic vesicle cycle, Tryptophan metabolism, Tyrosine metabolism 💬1件: 97 💬
473Phenylalanine1件: Phenylalanine1件: Phenylalanine 💬 --1件: 240 💬
474Phenylalanine (PHE)-restricted diet1件: Phenylalanine1件: Phenylalanine 💬 --1件: 240 💬
475Phenylalanine restricted diet1件: Phenylalanine1件: Phenylalanine 💬 --1件: 240 💬
476Phenylalanine-free milk1件: Phenylalanine1件: Phenylalanine 💬 --1件: 240 💬
477Phenylalanine-free protein substitute tablets1件: Phenylalanine1件: Phenylalanine 💬 --1件: 240 💬
478Phenylbutyrate1件: Phenylbutyric acid1件: Sodium phenylbutyrate 💬 --7件: 2, 93, 94, 244, 251, 297, 338 💬
479Phenylbutyrate oral tablet1件: Phenylbutyric acid1件: Sodium phenylbutyrate 💬 --1件: 15 💬
480Phenylcyclopropylamine derivatives and dual LSD1/MAO-B (lysine-specific demethylase 1 and monoamine oxidase-B) inhibitor----1件: 13 💬
481Phenylephrine1件: Phenylephrine3件: Phenylephrine hydrochloride ,
Phenylephrine ,
Phenylephrine bitartrate 💬 		3件: ADRA1A,
ADRA1B,
ADRA1D 💬 		9件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 22 💬
482Phenylketonuria-type diet----1件: 240 💬
483Phenytoin1件: Phenytoin2件: Phenytoin ,
Phenytoin sodium 💬 		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 13 💬
484Pheripheral blood stem cells----1件: 65 💬
485Phlebotomy----3件: 89, 158, 254 💬
486Phonation----1件: 6 💬
487Phosphate1件: Phosphate ion---13件: 3, 11, 13, 46, 65, 70, 75, 90, 235, 238, 256, 286, 288 💬
488Phosphate buffer saline (PBS), PH 7.01件: Phosphate ion---1件: 65 💬
489Phosphate-buffered saline1件: Phosphate ion---1件: 49 💬
490Phosphodiesterase inhibitors----1件: 51 💬
491Phosphorodiamidate morpholino oligomer----1件: 113 💬
492Phosphorodiamidate morpholino oligomer FOR exon 45 skipping----1件: 113 💬
493Phosphorodiamidate morpholino oligomer FOR exon 53 skipping----1件: 113 💬
494Phosphorous magnetic resonance spectroscopy1件: Phosphorus---1件: 58 💬
495Phosphorus1件: Phosphorus---1件: 238 💬
496PHP-303----1件: 231 💬
497PHQ-8----1件: 299 💬
498PHVS416----1件: 65 💬
499Phylloquinone1件: Phylloquinone1件: Phytonadione 💬 --1件: 96 💬
500Physalis angulata ethanol extract----1件: 51 💬
501Physical exam----2件: 215, 216 💬
502Physical examination----2件: 49, 172 💬
503Physical examination and questionnaires----1件: 98 💬
504Physical exercise program----1件: 49 💬
505Physical function performance test----1件: 6 💬
506Physical therapy----2件: 6, 70 💬
507Physician standard-OF-care----1件: 96 💬
508Physician-prescribed exercise programme----1件: 97 💬
509Physiologic serum nebulized nasally----1件: 299 💬
510Physiological saline----1件: 51 💬
511Physiological solution----1件: 299 💬
512Physiologische kochsalzloesung fresenius - infusionsloesung----1件: 227 💬
513Physiologische kochsalzlösung fresenius - infusionslösung----1件: 288 💬
514Physiotherapy, exercise, percutaneous gastrostomy feeds----1件: 299 💬
515Phytomenadione1件: Phylloquinone1件: Phytonadione 💬 --1件: 288 💬
516PI-08241件: PI-0824---1件: 35 💬
517PI-2301----1件: 13 💬
518Picc or other central line placement----1件: 19 💬
519Picibanil1件: Picibanil1件: Picibanil 💬 --1件: 278 💬
520Piclidenoson1件: Piclidenoson1件: Piclidenoson 💬 1件: ADORA3 💬 4件: Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 46 💬
521Piclozotan1件: Piclozotan---1件: 6 💬
522Picosulfate1件: Picosulfuric acid---1件: 97 💬
523Picture OF THE feet----1件: 46 💬
524PID----1件: 65 💬
525PIG whipworm eggs----1件: 46 💬
526Pilocarpine1件: Pilocarpine3件: Pilocarpine ,
Pilocarpine hydrochloride ,
Pilocarpine nitrate 💬 		2件: CHRM2,
CHRM3 💬 		14件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬3件: 6, 53, 299 💬
527Pilocarpine hydrochloride1件: Pilocarpine3件: Pilocarpine ,
Pilocarpine hydrochloride ,
Pilocarpine nitrate 💬 		2件: CHRM2,
CHRM3 💬 		14件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 53 💬
528Pilocarpine iontophoresis1件: Pilocarpine3件: Pilocarpine ,
Pilocarpine hydrochloride ,
Pilocarpine nitrate 💬 		2件: CHRM2,
CHRM3 💬 		14件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 299 💬
529Pilocarpine microneedle patch1件: Pilocarpine3件: Pilocarpine ,
Pilocarpine hydrochloride ,
Pilocarpine nitrate 💬 		2件: CHRM2,
CHRM3 💬 		14件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 299 💬
530Pimavanserin1件: Pimavanserin1件: Pimavanserin tartrate 💬 2件: HTR2,
HTR2 💬 		6件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬1件: 6 💬
531Pimavanserin 34 MG1件: Pimavanserin1件: Pimavanserin tartrate 💬 2件: HTR2,
HTR2 💬 		6件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬1件: 6 💬
532Pimavanserin tartrate1件: Pimavanserin1件: Pimavanserin tartrate 💬 2件: HTR2,
HTR2 💬 		6件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬1件: 6 💬
533Pimecrolimus 1% cream1件: Pimecrolimus1件: Pimecrolimus 💬 5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 160 💬
534Pimozide1件: Pimozide1件: Pimozide 💬 2件: ADRA2A,
DRD2 💬 		11件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 2 💬
535Pimozide 2 MG PER DAY1件: Pimozide1件: Pimozide 💬 2件: ADRA2A,
DRD2 💬 		11件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 2 💬
536Pimozide 4 MG PER DAY1件: Pimozide1件: Pimozide 💬 2件: ADRA2A,
DRD2 💬 		11件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 2 💬
537Pinaverium bromide1件: Pinaverium1件: Pinaverium bromide 💬 1件: CACNA1S 💬 27件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Cardiac muscle contraction, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, GABAergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 298 💬
538Pioglitazone1件: Pioglitazone2件: Pioglitazone hydrochloride ,
Pioglitazone 💬 		1件: NR1C3 💬 12件: AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬16件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 81, 86, 220, 229, 265, 298, 299 💬
539Pioglitazone 15 MG1件: Pioglitazone2件: Pioglitazone hydrochloride ,
Pioglitazone 💬 		1件: NR1C3 💬 12件: AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 96 💬
540Pioglitazone and tretinoin2件: Pioglitazone,
Tretinoin		3件: Tretinoin ,
Pioglitazone hydrochloride ,
Pioglitazone 💬 		4件: NR1C3,
PML,
RARA,
RARB 💬 		22件: AMPK signaling pathway, Acute myeloid leukemia, Efferocytosis, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Huntington disease, Influenza A, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬1件: 2 💬
541Pioglitazone or metformin1件: Pioglitazone2件: Pioglitazone hydrochloride ,
Pioglitazone 💬 		1件: NR1C3 💬 12件: AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 265 💬
542PIPE-307----1件: 13 💬
543PIPE-307 dose A----1件: 13 💬
544PIPE-307 dose B----1件: 13 💬
545PIPE-791----2件: 13, 85 💬
546Piperacillin1件: Piperacillin3件: Piperacillin sodium ,
Piperacillin ,
Piperacillin 💬 		--1件: 299 💬
547Piperacillin sodium1件: Piperacillin3件: Piperacillin sodium ,
Piperacillin ,
Piperacillin 💬 		--1件: 299 💬
548Piperacillin sodium , tazobactam sodium1件: Piperacillin3件: Piperacillin sodium ,
Piperacillin ,
Piperacillin 💬 		--1件: 299 💬
549Piperacillin-tazobactam combination product1件: Piperacillin3件: Piperacillin sodium ,
Piperacillin ,
Piperacillin 💬 		--1件: 299 💬
550Piperacillin/tazobactam1件: Piperacillin3件: Piperacillin sodium ,
Piperacillin ,
Piperacillin 💬 		--1件: 299 💬
551Piperacillin/tazobactam kabi - fresenius kabi austria2件: Piperacillin,
Tazobactam		5件: Piperacillin sodium ,
Tazobactam ,
Piperacillin ,
Tazobactam sodium ,
Piperacillin 💬 		--1件: 299 💬
552Piperacilline/tazobactam fresenius kabi 2 G/0,25 G poeder voor oplossing voor infusie1件: Tazobactam2件: Tazobactam ,
Tazobactam sodium 💬 		--1件: 299 💬
553Piperacilline/tazobactam fresenius kabi 4 G/0,5 G poeder voor oplossing voor infusie1件: Tazobactam2件: Tazobactam ,
Tazobactam sodium 💬 		--1件: 299 💬
554Piperazine1件: Piperazine5件: Piperazine ,
Piperazine phosphate ,
Piperazine citrate ,
Piperazine adipate ,
Piperazine hexahydrate 💬 		--1件: 272 💬
555PIR, S-7701----1件: 85 💬
556Pirepemat1件: Pirepemat---1件: 6 💬
557Pirepemat X fumarate1件: Pirepemat---1件: 6 💬
558Pirepemat, 100 MG1件: Pirepemat---1件: 6 💬
559Pirepemat, 50 MG1件: Pirepemat---1件: 6 💬
560Pirfenidone1件: Pirfenidone1件: Pirfenidone 💬 6件: CCL2,
IL10,
IL1A,
IL1B,
IL6,
TNF 💬 		83件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
561Pirfenidone and nintedanib1件: Pirfenidone1件: Pirfenidone 💬 6件: CCL2,
IL10,
IL1A,
IL1B,
IL6,
TNF 💬 		83件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 85 💬
562Pirfenidone modified-release tablets1件: Pirfenidone1件: Pirfenidone 💬 6件: CCL2,
IL10,
IL1A,
IL1B,
IL6,
TNF 💬 		83件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 85 💬
563Pirfenidone or nintedanib1件: Pirfenidone1件: Pirfenidone 💬 6件: CCL2,
IL10,
IL1A,
IL1B,
IL6,
TNF 💬 		83件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 85 💬
564Pirfenidone solution FOR inhalation1件: Pirfenidone1件: Pirfenidone 💬 6件: CCL2,
IL10,
IL1A,
IL1B,
IL6,
TNF 💬 		83件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 85 💬
565Pirfenidone tablets1件: Pirfenidone1件: Pirfenidone 💬 6件: CCL2,
IL10,
IL1A,
IL1B,
IL6,
TNF 💬 		83件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 85 💬
566Pirfenidone, deuterated1件: Pirfenidone1件: Pirfenidone 💬 6件: CCL2,
IL10,
IL1A,
IL1B,
IL6,
TNF 💬 		83件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 85 💬
567Pirfenidoneone----1件: 85 💬
568Piribedil1件: Piribedil1件: Piribedil 💬 2件: DRD2,
DRD3 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
569Pirtobrutinib1件: Pirtobrutinib1件: Pirtobrutinib 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 13 💬
570PIT565----1件: 49 💬
571Pitavastatin1件: Pitavastatin2件: Pitavastatin calcium ,
Pitavastatin magnesium 💬 		1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬1件: 49 💬
572Pitolisant1件: Pitolisant2件: Pitolisant ,
Pitolisant hydrochloride 💬 		1件: HRH3 💬 2件: Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 6 💬
573Pitolisant oral tablet1件: Pitolisant2件: Pitolisant ,
Pitolisant hydrochloride 💬 		1件: HRH3 💬 2件: Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 113 💬
574Pitolisant oral tablets1件: Pitolisant2件: Pitolisant ,
Pitolisant hydrochloride 💬 		1件: HRH3 💬 2件: Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 193 💬
575Pitolisant tablet1件: Pitolisant2件: Pitolisant ,
Pitolisant hydrochloride 💬 		1件: HRH3 💬 2件: Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 193 💬
576Pittsburgh compound B1件: Pittsburgh Compound B---1件: 127 💬
577Pittsburgh compound B [11C]-PIB1件: Pittsburgh Compound B---1件: 6 💬
578Pixantrone1件: Pixantrone2件: Pixantrone ,
Pixantrone dimaleate 💬 		--2件: 11, 13 💬
579PK-merz® 200MG/500ML INJ(amantadine) , normal saline 500ML INJ----1件: 6 💬
580PK-model TO decide when TO dose vedolizumab and ustekinumab----2件: 96, 97 💬
581PK/PD model based dosing OF digoxin IN infants with single ventricle heart disease----1件: 210 💬
582PKD patients----1件: 6 💬
583PKU easy microtabs plus----1件: 240 💬
584PKU explore----1件: 240 💬
585PKU express plus----2件: 244, 337 💬
586PKU golike----1件: 240 💬
587PKU sphere----1件: 240 💬
588PKU sphere liquid----1件: 240 💬
589PKU start----1件: 240 💬
590PKU UP----1件: 240 💬
591PKU/TYR GMP protein substitute----1件: 240 💬
592PL 00095/5079R----1件: 46 💬
593PL 0010/0211----1件: 299 💬
594PL 00512/0150----1件: 298 💬
595PL 04515/0127----1件: 13 💬
596PL 12762/0049----1件: 13 💬
597PL 17901/0122----1件: 96 💬
598PL 20532/0012----1件: 96 💬
599PL101----1件: 8 💬
600PL8177----1件: 97 💬
601PLA + MTX switched TO ABA+ MTX, DB----1件: 46 💬
602PLA-695----1件: 46 💬
603PLA-PRU-PLA-PRU----1件: 99 💬
604PLA-PRU-PRU-PLA----1件: 99 💬
605Placental mesenchymal stem cells seeded ON A commercially available dural graft extracellular matrix1件: Placental Mesenchymal Stem Cells---1件: 118 💬
606Placentex ® polydeoxyribonucleotide----1件: 51 💬
607Placentex ¿ polydeoxyribonucleotide 5.625 MG/3 ML----1件: 51 💬
608Plaebo----1件: 46 💬
609Planar image with both hands IN field OF view----1件: 46 💬
610Planar images----1件: 98 💬
611Plant cell recombinant glucocerebrosidase----1件: 19 💬
612Plant-based diet----1件: 46 💬
613Plantago ovata husk----1件: 6 💬
614Plantain NSP----1件: 96 💬
615Plaquenil1件: Hydroxychloroquine2件: Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		--5件: 46, 49, 53, 84, 96 💬
616Plaquenil - hydroxychloroquine 200MG film coated tablets1件: Hydroxychloroquine2件: Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		--3件: 43, 44, 45 💬
617Plaquenil 200 MG filmdrasjerte tabletter----1件: 46 💬
618Plaquenil*25CPR RIV 200MG1件: Hydroxychloroquine2件: Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		--1件: 84 💬
619Plasma analysis FOR bacterial translocation----1件: 46 💬
620Plasma exchange----7件: 13, 43, 44, 64, 95, 171, 222 💬
621Plasma from healthy young people treatment + riluzole1件: Riluzole1件: Riluzole 💬 14件: GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		24件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬1件: 2 💬
622Plasma RNA isolation, qpcr analysis OF micro RNA----1件: 63 💬
623Plasma-derived fviii/VWF concentrate----1件: 288 💬
624Plasmapheresis----4件: 11, 49, 113, 222 💬
625Plasmasafe----1件: 274 💬
626Plasticity-based computerized cognitive remediation program----1件: 13 💬
627Platelet enriched plasma----1件: 226 💬
628Platelet function analyzer-100----2件: 86, 88 💬
629Platelet GEL----1件: 51 💬
630Platelet rich plasma1件: Platelet Rich Plasma---4件: 46, 47, 70, 90 💬
631Platelet rich plasma therapy1件: Platelet Rich Plasma---1件: 269 💬
632Platelet transfusion----1件: 13 💬
633Platelet-rich plasma----1件: 226 💬
634Platform----1件: 13 💬
635Plavix1件: Clopidogrel4件: Clopidogrel bisulfate ,
Clopidogrel ,
Clopidogrel hydrochloride ,
Clopidogrel besilate 💬 		1件: P2RY12 💬 3件: Efferocytosis, Neuroactive ligand signaling, Platelet activation 💬1件: 51 💬
636Plcacebo----1件: 67 💬
637Pleconaril1件: Pleconaril1件: Pleconaril 💬 --1件: 2 💬
638Pledigry----1件: 13 💬
639Plegridy1件: Peginterferon beta-1a1件: Peginterferon beta-1a 💬 2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
640Plegridy (peginterferon BETA-1A), biogen idec LTD1件: Peginterferon beta-1a1件: Peginterferon beta-1a 💬 2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
641Plegridy - 125 MCG - soluzione iniettabile - USO sottocutaneo - penna preriempita - 0,5 ML - 6 penne preriempite----1件: 13 💬
642Plegridy 125 micrograms1件: Peginterferon beta-1a1件: Peginterferon beta-1a 💬 2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
643Plegridy 63 micrograms1件: Peginterferon beta-1a1件: Peginterferon beta-1a 💬 2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
644Plenadren 20 MG modified-release tablets1件: Hydrocortisone1件: Hydrocortisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 78 💬
645Plenadren 5 MG modified-release tablets1件: Hydrocortisone1件: Hydrocortisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 78 💬
646Pleneva TM BGC20-0134----1件: 13 💬
647Plenur----1件: 2 💬
648Plerixafor1件: Plerixafor1件: Plerixafor 💬 1件: CXCR4 💬 14件: Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬4件: 20, 51, 65, 285 💬
649Plerixafor mobilization OF autologous CD117 stem cells1件: Plerixafor1件: Plerixafor 💬 1件: CXCR4 💬 14件: Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬1件: 299 💬
650Pletal1件: Cilostazol1件: Cilostazol 💬 3件: PDE3A,
PDE3B,
TBXA2R 💬 		13件: Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Platelet activation, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 51 💬
651Plex----1件: 11 💬
652PLF with autograft----1件: 70 💬
653PLF with neofuse----1件: 70 💬
654PLL001----1件: 2 💬
655PLN-748091件: PLN-74809---2件: 85, 94 💬
656PLN-74809-0001件: PLN-74809---1件: 85 💬
657PLN-74809-0201件: PLN-74809---1件: 85 💬
658Plovamer acetate----1件: 13 💬
659Plovamer acetate 10 MG----1件: 13 💬
660Plovamer acetate 20 MG----1件: 13 💬
661Plovamer acetate 3 MG----1件: 13 💬
662PLP peptide----1件: 13 💬
663PLX-200----1件: 19 💬
664PLX-PAD1件: PLX-PAD---1件: 86 💬
665PLX3397----1件: 46 💬
666PLX5622----1件: 46 💬
667PLérixafor----1件: 285 💬
668PM359----1件: 65 💬
669PMG1015----1件: 85 💬
670PMG1015 dose 1----1件: 85 💬
671PMG1015 dose 2----1件: 85 💬
672PMG1015 dose 3----1件: 85 💬
673PMG1015 dose 4----1件: 85 💬
674PMG1015 dose 5----1件: 85 💬
675PMG1015 dose 6----1件: 85 💬
676PMG1015 dose 7----1件: 85 💬
677PN-101----1件: 50 💬
678PN-10884A----1件: 97 💬
679PN-800467----1件: 77 💬
680PN-943----1件: 97 💬
681PN20----1件: 63 💬
682PN20 treatment----1件: 63 💬
683Pncj PPS----1件: 65 💬
684Pnemovax----1件: 96 💬
685Pneumo 23----2件: 65, 97 💬
686Pneumo23----1件: 107 💬
687Pneumo23 / pneumovax----1件: 46 💬
688Pneumococcal conjugate vaccine----1件: 46 💬
689Pneumococcal pneumonia vaccine----1件: 97 💬
690Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) conjugated TO CRM197 carrier protein and adsorbed ON aluminium phosphate----1件: 46 💬
691Pneumococcal polysaccharide serotype 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F and 33F----1件: 46 💬
692Pneumococcal polysaccharide serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F----1件: 46 💬
693Pneumococcal polysaccharide serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 23F----1件: 222 💬
694Pneumococcal polysaccharide serotype 11 2.2 µG----1件: 222 💬
695Pneumococcal polysaccharide vaccine----2件: 13, 46 💬
696Pneumococcal polysaccharide vaccine 23 valent----1件: 265 💬
697Pneumococcal polysaccharide vaccine solution FOR injection IN A vial----1件: 222 💬
698Pneumococcal serotypes----1件: 46 💬
699Pneumovax----4件: 46, 49, 96, 97 💬
700Pneumovax - 10 siringhe preriempite CON AGO DA 0.5 ML----1件: 62 💬
701Pneumovax 23----2件: 46, 50 💬
702Pneumovax II----1件: 13 💬
703Pneumovax – soluzione iniettabile IN siringa preriempita DA 0,5 ML----2件: 62, 66 💬
704Pneumovax® 23----1件: 46 💬
705PNF----1件: 13 💬
706PNU-215062 sodium salt----1件: 13 💬
707PO azithromycin----1件: 299 💬
708PO ciprofloxacin----1件: 299 💬
709POL6014----1件: 299 💬
710POL7080----1件: 299 💬
711Polaprezinc1件: Polaprezinc1件: Polaprezinc 💬 --2件: 96, 97 💬
712Polar H10 heart sensor----1件: 6 💬
713Polidocanol1件: Polidocanol2件: Laureth 4 ,
Polidocanol 💬 		--3件: 34, 278, 279 💬
714Polietilenglicole----1件: 97 💬
715Polisaccaride dell'haemophilus influenzae DI tipo B coniugato CON LA proteina tetanica----1件: 62 💬
716Poly iclc1件: Hiltonol---1件: 34 💬
717Poly(OXY-1,2-ethanediyl), alpha-hydro-omega-methoxy, ether with N-[[[2-[[6-[[1-[3-[[3-(2,3-dihydroxypropoxy)propyl]amino]-3-oxopropyl]-2,5-DI1件: Diethyl ether1件: Ether 💬 --1件: 235 💬
718Poly(OXY-1,2-ethanediyl), alpha-hydro-omega-methoxy, ether with N-[[[2-[[6-[[1-[3-[[3-(2,3-dihydroxypropoxy)propyl]amino]-3-oxopropyl]-2,5-dioxo-3-pyrrolidinyl]thio]hexyl]amino]ethyl]amino]carbon1件: Diethyl ether1件: Ether 💬 --1件: 235 💬
719POLY-L-D-lactic acid implant (regjoint) interposition arthroplasty----1件: 46 💬
720POLY-L-lactic acid1件: Poly(lactic acid)---1件: 265 💬
721Polyclonal IGG----1件: 65 💬
722Polydeoxyribonucleotides----2件: 51, 70 💬
723Polyethylene glycol1件: Polyethylene glycol3件: Polyethylene glycol 3350 ,
Macrogol 4000 ,
Macrogol 6000 💬 		--4件: 50, 97, 195, 299 💬
724Polyethylene glycol 33501件: Polyethylene glycol3件: Polyethylene glycol 3350 ,
Macrogol 4000 ,
Macrogol 6000 💬 		--2件: 96, 299 💬
725Polyethylene glycol preparation1件: Polyethylene glycol3件: Polyethylene glycol 3350 ,
Macrogol 4000 ,
Macrogol 6000 💬 		--1件: 96 💬
726Polyethylene glycols----1件: 97 💬
727Polymerase chain reaction----4件: 28, 60, 65, 285 💬
728Polymorphism analysis----2件: 49, 60 💬
729Polymva----1件: 2 💬
730Polyphenon E1件: Sinecatechins1件: Sinecatechins 💬 --3件: 13, 36, 97 💬
731Polysomnogram----1件: 6 💬
732Pomalidomida1件: Pomalidomide1件: Pomalidomide 💬 2件: IL6,
TNF 💬 		78件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 51 💬
733Pomalidomide1件: Pomalidomide1件: Pomalidomide 💬 2件: IL6,
TNF 💬 		78件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬5件: 28, 34, 51, 227, 331 💬
734Pomalidomide (CC-40471件: Pomalidomide1件: Pomalidomide 💬 2件: IL6,
TNF 💬 		78件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 85 💬
735Pomalidomide 4 MG1件: Pomalidomide1件: Pomalidomide 💬 2件: IL6,
TNF 💬 		78件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 28 💬
736Pomalidomide and dexamethasone1件: Pomalidomide1件: Pomalidomide 💬 2件: IL6,
TNF 💬 		78件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 28 💬
737Pomalidomide oral product1件: Pomalidomide1件: Pomalidomide 💬 2件: IL6,
TNF 💬 		78件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 227 💬
738Ponesimod1件: Ponesimod1件: Ponesimod 💬 1件: S1PR1 💬 4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
739Ponesimod 10 MG1件: Ponesimod1件: Ponesimod 💬 1件: S1PR1 💬 4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
740Ponesimod 20 MG1件: Ponesimod1件: Ponesimod 💬 1件: S1PR1 💬 4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
741Ponesimod 40 MG1件: Ponesimod1件: Ponesimod 💬 1件: S1PR1 💬 4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
742Ponticelli regimen----1件: 222 💬
743Ponvory1件: Ponesimod1件: Ponesimod 💬 1件: S1PR1 💬 4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
744Pooled mesenchymal stem cell----1件: 49 💬
745Pooled plasma (human), solvent/detergent treated----1件: 64 💬
746Porcine (PIG) pert----1件: 299 💬
747Porcine pert----1件: 299 💬
748Porphozym1件: Porphobilinogen deaminase, human recombinant---1件: 254 💬
749PORT-77----1件: 254 💬
750Portable cardiac monitor cardioqvark----2件: 89, 299 💬
751Posaconazole1件: Posaconazole1件: Posaconazole 💬 --3件: 60, 65, 299 💬
752Posaconazole 40 MG/ML1件: Posaconazole1件: Posaconazole 💬 --1件: 299 💬
753Posaconazole delayed release oral tablet1件: Posaconazole1件: Posaconazole 💬 --1件: 96 💬
754Posaconazolo----1件: 299 💬
755Posiphen1件: Posiphen---1件: 6 💬
756Position sense----1件: 13 💬
757Positive expiratory pressure----1件: 299 💬
758Positron emission tomography----6件: 26, 28, 40, 46, 49, 96 💬
759POST-transplant G-CSF----3件: 60, 62, 283 💬
760Posterolateral spinal fusion with instrumentation----1件: 70 💬
761Postoperative 3-month exclusive enteral nutrition----1件: 96 💬
762Postoperative laboratory blood tests AT 24 hour----1件: 235 💬
763Postoperative laboratory blood tests AT 6 hour----1件: 235 💬
764Postoperative laboratory drainage fluid tests AT 24 hour----1件: 235 💬
765Postoperative nausea and vomiting AT 24 hour----1件: 235 💬
766Postoperative nausea and vomiting AT 6 hour----1件: 235 💬
767Postoperative pain AT 24 hour----1件: 235 💬
768Postoperative pain AT 6 hour----1件: 235 💬
769Postoperative sore throat and hoarseness AT 24 hour----1件: 235 💬
770Postoperative sore throat and hoarseness AT 6 hour----1件: 235 💬
771Posturological examination ON kplates and amti platforms----1件: 10 💬
772Potable water----1件: 19 💬
773Potassio solfato----1件: 97 💬
774Potassium1件: Potassium1件: Potassium 💬 --3件: 66, 67, 115 💬
775Potassium chloride2件: Potassium,
Potassium chloride		2件: Potassium chloride ,
Potassium 💬 		--1件: 97 💬
776Potassium sparing diuretic1件: Potassium1件: Potassium 💬 --1件: 235 💬
777Potassium sulphate2件: Potassium,
Potassium sulfate		2件: Potassium sulfate ,
Potassium 💬 		--1件: 97 💬
778Potassium supplement1件: Potassium1件: Potassium 💬 --1件: 46 💬
779Potiga1件: Ezogabine1件: Ezogabine 💬 5件: KCNQ1,
KCNQ2,
KCNQ3,
KCNQ4,
KCNQ5 💬 		6件: Adrenergic signaling in cardiomyocytes, Cholinergic synapse, Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Vibrio cholerae infection 💬1件: 144 💬
780Povetacicept1件: Povetacicept1件: Povetacicept 💬 1件: TNFRSF13B 💬 3件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, Primary immunodeficiency 💬3件: 61, 63, 222 💬
781Power doppler ultrasonography----1件: 46 💬
782Powerlung trainer----1件: 2 💬
783Pozelimab1件: Pozelimab1件: Pozelimab 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬2件: 11, 62 💬
784Pozelimab + cemdisiran2件: Cemdisiran,
Pozelimab		1件: Pozelimab 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 11 💬
785Pozelimab/cemdisiran1件: Pozelimab1件: Pozelimab 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 15 💬
786PPI treatment----1件: 299 💬
787PPT----1件: 271 💬
788PR oxycodone----1件: 6 💬
789PR-06410293----1件: 46 💬
790PR006A----1件: 127 💬
791PR1----2件: 2, 51 💬
792PRA023----3件: 51, 96, 97 💬
793PRA023 IV----1件: 96 💬
794Praluent1件: Alirocumab1件: Alirocumab 💬 1件: PCSK9 💬 1件: Cholesterol metabolism 💬1件: 79 💬
795Pramipexol1件: Pramipexole2件: Pramipexole dihydrochloride ,
Pramipexole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
796Pramipexol extended release1件: Pramipexole2件: Pramipexole dihydrochloride ,
Pramipexole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
797Pramipexol immediate release1件: Pramipexole2件: Pramipexole dihydrochloride ,
Pramipexole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
798Pramipexole1件: Pramipexole2件: Pramipexole dihydrochloride ,
Pramipexole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬2件: 6, 20 💬
799Pramipexole 0.125 MG tablets1件: Pramipexole2件: Pramipexole dihydrochloride ,
Pramipexole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
800Pramipexole 0.5 MG tablets1件: Pramipexole2件: Pramipexole dihydrochloride ,
Pramipexole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
801Pramipexole 0.6 MG1件: Pramipexole2件: Pramipexole dihydrochloride ,
Pramipexole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
802Pramipexole dihydrochloride extended-release tablets1件: Pramipexole2件: Pramipexole dihydrochloride ,
Pramipexole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
803Pramipexole dihydrochloride monohydrate1件: Pramipexole2件: Pramipexole dihydrochloride ,
Pramipexole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
804Pramipexole dihydrochloride monohydrate extended release1件: Pramipexole2件: Pramipexole dihydrochloride ,
Pramipexole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
805Pramipexole ER1件: Pramipexole2件: Pramipexole dihydrochloride ,
Pramipexole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
806Pramipexole extended release1件: Pramipexole2件: Pramipexole dihydrochloride ,
Pramipexole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
807Pramipexole extended release tablet1件: Pramipexole2件: Pramipexole dihydrochloride ,
Pramipexole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
808Pramipexole immediate release1件: Pramipexole2件: Pramipexole dihydrochloride ,
Pramipexole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
809Pramipexole immediate release tablet1件: Pramipexole2件: Pramipexole dihydrochloride ,
Pramipexole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
810Pramipexole IR1件: Pramipexole2件: Pramipexole dihydrochloride ,
Pramipexole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
811Pramipexole or ropinirole1件: Pramipexole2件: Pramipexole dihydrochloride ,
Pramipexole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
812Pramipexole SR1件: Pramipexole2件: Pramipexole dihydrochloride ,
Pramipexole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
813Prasinezumab1件: Prasinezumab1件: Prasinezumab 💬 1件: SNCA 💬 3件: Alzheimer disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬1件: 6 💬
814Prasterone1件: Prasterone1件: Prasterone 💬 3件: AR,
ESR1,
ESR2 💬 		12件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 49 💬
815Pravastatin1件: Pravastatin2件: Pravastatin sodium ,
Pravastatin 💬 		1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬10件: 13, 46, 49, 67, 79, 96, 164, 210, 265, 333 💬
816Pravastatin sodium1件: Pravastatin2件: Pravastatin sodium ,
Pravastatin 💬 		1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬1件: 265 💬
817PRD2175434----1件: 113 💬
818PRD4862257----1件: 46 💬
819PRD5973697----1件: 97 💬
820PRD806998----1件: 13 💬
821PRE liver transplantation laparoscopic hand assisted staging----1件: 94 💬
822PRE-filled syringe----7件: 46, 49, 53, 96, 97, 107, 271 💬
823PRE-genotype NUDT15 and optimize azathioprine dosage----1件: 97 💬
824PRE-treatment with octreotide----1件: 77 💬
825Prebiotic----2件: 96, 97 💬
826Prebiotics----2件: 96, 97 💬
827Prebiotics and probiotics supplementation----1件: 13 💬
828Prebiotics with galactomannan and oligofructose----1件: 193 💬
829Precedentemente denominato MEDI2070 E AMG 139----1件: 96 💬
830Precision dosing infliximab----1件: 97 💬
831Precision dosing with A dashboard----1件: 96 💬
832Pred----1件: 46 💬
833Pred + meth----1件: 46 💬
834Predinose oral----1件: 70 💬
835Prednihexal----1件: 46 💬
836Prednihexal® 5MG tabletten, prednihexal® 10MG tabletten----1件: 46 💬
837Prednihexal® 5MG tabletten, prednihexal® 20MG tabletten----1件: 46 💬
838Predniso----1件: 46 💬
839Prednisolene tablets BP 1 MG----1件: 46 💬
840Prednisolon----7件: 46, 51, 66, 95, 96, 97, 251 💬
841Prednisolon 1 MG jenapharm----1件: 41 💬
842Prednisolon 10 MG jenapharm----1件: 41 💬
843Prednisolon 20 MG jenapharm----1件: 41 💬
844Prednisolon 5 MG jenapharm----1件: 41 💬
845Prednisolon jenapharm----2件: 96, 97 💬
846Prednisolon pfizer----2件: 46, 50 💬
847Prednisolona1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 51 💬
848Prednisolone1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬38件: 3, 11, 13, 14, 18, 25, 26, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 54, 56, 60, 63, 64, 66, 81, 84, 85, 96, 97, 113, 145, 162, 222, 251, 269, 271, 296, 299, 300 💬
849Prednisolone & dipyridamole1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
850Prednisolone + mabthera1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 61 💬
851Prednisolone - prednisolone tablet1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
852Prednisolone 1MG tablets1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
853Prednisolone 2,5 MG tablets1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
854Prednisolone 20 MG1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
855Prednisolone 40 MG1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
856Prednisolone 5 MG1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 46, 51 💬
857Prednisolone 5 MG tablets1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
858Prednisolone 5MG gastro-resistant tablets1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 51 💬
859Prednisolone 5MG tablet1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
860Prednisolone acetate2件: Prednisolone,
Prednisolone acetate		2件: Prednisolone ,
Prednisolone acetate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 222 💬
861Prednisolone and chlorambucil1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 222 💬
862Prednisolone and mycophenolate mofetil1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 222 💬
863Prednisolone and taper1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 51 💬
864Prednisolone labesfal1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
865Prednisolone plus cyclophosphamide1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 66 💬
866Prednisolone sodium metasulphobenzoate1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
867Prednisolone sodium phosphate1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 3 💬
868Prednisolone sodium phosphate oral solution1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 3 💬
869Prednisolone sodium succinate1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 95 💬
870Prednisolone tablets B.P. 5MG1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
871Prednisolone tablets BP1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
872Prednisolone tablets BP 1 MG1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
873Prednisolone tablets USP 5 MG1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
874Prednisolone-dipyridamole1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
875Prednisolone/prednisone1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 49 💬
876Prednisoloni----1件: 51 💬
877Prednisolonum1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 51 💬
878Prednison----4件: 46, 84, 113, 300 💬
879Prednison 10 MG galen----1件: 35 💬
880Prednison 5 MG galen----1件: 35 💬
881Prednison 5, 20 Léciva POR. tablet NOB----1件: 50 💬
882Prednison 50 MG galen----1件: 35 💬
883Prednison acis® 20 MG----2件: 43, 44 💬
884Prednison acis® 5 MG----2件: 43, 44 💬
885Prednison acis¿ 20 MG----2件: 43, 44 💬
886Prednison acis¿ 5 MG----2件: 43, 44 💬
887Prednison20 MG galen----1件: 35 💬
888Prednisona1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 49, 222 💬
889Prednisone1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬54件: 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 145, 162, 164, 205, 222, 224, 228, 251, 269, 283, 285, 288, 299, 300, 303, 307, 331 💬
890Prednisone - azathioprine1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 11 💬
891Prednisone 0,5 MG/KG orally ON alternate days1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 222 💬
892Prednisone 1 MG1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
893Prednisone 15 MG1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
894Prednisone 2 MG1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
895Prednisone 3 MG1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
896Prednisone 4 MG1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
897Prednisone 5 MG1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 46, 66 💬
898Prednisone 5 MG tablets1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 113 💬
899Prednisone 7.5 MG1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
900Prednisone acetate2件: Prednisone,
Prednisone acetate		2件: Prednisone ,
Prednisone acetate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬6件: 35, 46, 49, 63, 162, 222 💬
901Prednisone acetate tablets2件: Prednisone,
Prednisone acetate		2件: Prednisone ,
Prednisone acetate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 40, 224 💬
902Prednisone alone1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 11, 66 💬
903Prednisone and belimumab1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 300 💬
904Prednisone and cyclophosphamide1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 66 💬
905Prednisone and mycophenolate mofetil1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 300 💬
906Prednisone and ustekinumab treatment1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
907Prednisone arrow 20MG1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 66 💬
908Prednisone arrow 5 MG1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 66 💬
909Prednisone capsule1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
910Prednisone capsules1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
911Prednisone discontinuation1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 49 💬
912Prednisone DOC generici1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 90 💬
913Prednisone DOC generici - 5 MG compresse 10 compresse IN blister PVC-pvdc/ALU1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 19 💬
914Prednisone DOC generici - 5 MG compresse 30 compresse IN blister PVC-pvdc/ALU1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 300 💬
915Prednisone IN full dose1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 66 💬
916Prednisone or prednisolone1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 66, 84 💬
917Prednisone oral product1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
918Prednisone plus cyclophosphamide1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 66 💬
919Prednisone plus exercise1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 113 💬
920Prednisone tablet1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 63 💬
921Prednisone tablets USP, 1 MG1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 41, 46 💬
922Prednisone tablets USP, 10 MG1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
923Prednisone tablets USP, 1MG1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
924Prednisone tablets USP, 2.5 MG1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
925Prednisone tablets USP, 2.5MG1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
926Prednisone tablets USP, 20MG1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
927Prednisone tablets USP, 5 MG1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 41, 46 💬
928Prednisone tablets USP, 5MG1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
929Prednisone tablets, USP1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬3件: 41, 43, 44 💬
930Prednisone tablets, USP 10 MG1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
931Prednisone tablets, USP 2.5 MG1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
932Prednisone tablets, USP 5 MG1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
933Prednisone tablets, USP, 1 MG1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
934Prednisone therapy and pharmacokinetic1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
935Prednisone treatment1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
936Prednisone, ciclosporin and mycophenolate mofetil1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 222 💬
937Prednisone, cyclophosphamide1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 40 💬
938Prednisone, FK506, MMF1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 222 💬
939Prednisone, LOW dose rituximab1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 61 💬
940Prednisone, methylprednisolone,cyclophosphamides1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬3件: 42, 43, 45 💬
941Prednisone,methylprednisone and cyclophosphamide1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 222 💬
942Prednisone/methylprenisolone1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 96 💬
943Prednisone/prednisolone1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 35 💬
944Prednisonum micronisatum1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 85 💬
945Prednizolon----1件: 51 💬
946Prednizolonas----1件: 51 💬
947Prefilled syringe delivery OF golimumab----1件: 97 💬
948Prefolic----1件: 337 💬
949Prefolic 15*30CPR gastror 15MG----1件: 337 💬
950Prefolic*30CPR gastror 15MG----1件: 299 💬
951Pregabalin1件: Pregabalin1件: Pregabalin 💬 4件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4 💬 		7件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway 💬5件: 13, 36, 46, 70, 298 💬
952Pregabalin 75MG1件: Pregabalin1件: Pregabalin 💬 4件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4 💬 		7件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway 💬1件: 70 💬
953Pregnancy test----2件: 49, 50 💬
954Preladenant1件: Preladenant1件: Preladenant 💬 1件: ADORA2A 💬 8件: Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6 💬
955Preladenant 10 MG tablet1件: Preladenant1件: Preladenant 💬 1件: ADORA2A 💬 8件: Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6 💬
956Preladenant 2 MG tablet1件: Preladenant1件: Preladenant 💬 1件: ADORA2A 💬 8件: Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6 💬
957Preladenant 5 MG tablet1件: Preladenant1件: Preladenant 💬 1件: ADORA2A 💬 8件: Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6 💬
958Premarin and provera----1件: 49 💬
959Preoparative blood laboratory tests----1件: 235 💬
960Preoperative lanreotide treatment----1件: 77 💬
961Preotact1件: Parathyroid hormone1件: Parathyroid hormone 💬 2件: PTH1R,
PTHR2 💬 		4件: Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235 💬
962Preparative radiation therapy----1件: 240 💬
963Preparative regimen 4-6 weeks after leukapheresis----1件: 96 💬
964Prepulsid----1件: 13 💬
965Prescribe N-acetylcysteine tablets----1件: 90 💬
966Preservative-free parenteral treprostinil----1件: 86 💬
967Pressure pain threshold----4件: 3, 15, 113, 256 💬
968Pretreatment antibiotics----1件: 97 💬
969Prevenar----1件: 65 💬
970Prevenar 13----4件: 13, 46, 96, 97 💬
971Prevenar 13 - 0.5 ML sospension----1件: 62 💬
972Prevenar 13 - 0.5 ML sospensione iniettabile - USO intramuscolare - flaconcino monodose (0,5 ML vetro tipo I) - 1 flaconcino monodose----1件: 222 💬
973Prevenar 13 sospensione PER iniezione----1件: 14 💬
974Prevenar 13 suspension FOR injection----1件: 222 💬
975Prevenar vaccination----1件: 46 💬
976Prevenar vaccine----1件: 46 💬
977Prevenar13----2件: 19, 265 💬
978Previously known AS R935788----1件: 46 💬
979Previously referred TO AS MEDI2070 and AMG 139----1件: 97 💬
980Previously referred TO AS MEDI2070 and AMG 139, AGN-151-598----1件: 96 💬
981Previously termed SC.AAV9.CB.SMN and AVXS-101----1件: 3 💬
982PRG-1801----1件: 300 💬
983PRG-2311----1件: 300 💬
984Prgcd1件: Taliglucerase alfa1件: Taliglucerase alfa 💬 1件: GBA 💬 4件: Cornified envelope formation, Lysosome, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
985Pridia (donepezil hydrochloride) 5MG1件: Donepezil2件: Donepezil hydrochloride ,
Donepezil 💬 		1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬1件: 6 💬
986Pridia 10MG----1件: 6 💬
987Pridia 5MG----1件: 6 💬
988Pridiopidine----1件: 8 💬
989Pridopidina----1件: 8 💬
990Pridopidine1件: Pridopidine2件: Pridopidine ,
Pridopidine hydrochloride 💬 		1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬3件: 2, 6, 8 💬
991Pridopidine hydrochloride1件: Pridopidine2件: Pridopidine ,
Pridopidine hydrochloride 💬 		1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 8 💬
992PRIM-DJ2727----3件: 6, 51, 97 💬
993PRIM-DJ2727 - capsules----1件: 97 💬
994PRIM-DJ2727 - frozen----1件: 97 💬
995Primavanserin tartrate----1件: 6 💬
996Primec----1件: 2 💬
997Primidone1件: Primidone1件: Primidone 💬 --2件: 2, 113 💬
998Primus1件: Florasulam---1件: 46 💬
999Prior donepezil 5MG----1件: 6 💬
1000Prior donzepezil 10MG----1件: 6 💬
1001Privigen1件: Human immunoglobulin G1件: Globulin, immune 💬 --5件: 11, 14, 51, 63, 65 💬
1002Privigen 100 MG/ML, solution pour perfusion----1件: 53 💬
1003Privigen 100MG/ML----1件: 85 💬
1004Privigen® 100MG/ML AT THE dose OF 2G/KG OF body weight----1件: 53 💬
1005PRM-151----1件: 85 💬
1006PRN1008----4件: 35, 61, 63, 300 💬
1007PRN1008 100 MG tablet----1件: 63 💬
1008PRN1008 300 MG tablet----1件: 63 💬
1009PRN1008 400 MG tablet----1件: 63 💬
1010PRN1008 freebase----1件: 35 💬
1011PRN2246----2件: 11, 13 💬
1012PRO0441件: BMN-044---1件: 113 💬
1013PRO044 IV1件: BMN-044---1件: 113 💬
1014PRO044 IV 6 MG/KG1件: BMN-044---1件: 113 💬
1015PRO044 IV 9 MG/KG1件: BMN-044---1件: 113 💬
1016PRO044 SC1件: BMN-044---1件: 113 💬
1017PRO044 SC 6 MG/KG1件: BMN-044---1件: 113 💬
1018PRO0451件: BMN-045---1件: 113 💬
1019PRO045, 0.15 MG/KG/week1件: BMN-045---1件: 113 💬
1020PRO045, 1.0 MG/KG/week1件: BMN-045---1件: 113 💬
1021PRO045, 3.0 MG/KG/week1件: BMN-045---1件: 113 💬
1022PRO045, 6.0 MG/KG/week1件: BMN-045---1件: 113 💬
1023PRO045, 9.0 MG/KG/week1件: BMN-045---1件: 113 💬
1024PRO045, selected dose1件: BMN-045---1件: 113 💬
1025PRO051----1件: 113 💬
1026PRO0531件: BMN-053---1件: 113 💬
1027PRO145223----1件: 97 💬
1028PRO283698----1件: 46 💬
1029Probenecid1件: Probenecid1件: Probenecid 💬 --1件: 25 💬
1030Probiotic1件: Lactobacillus acidophilus1件: Lactomin 💬 --9件: 2, 6, 93, 96, 97, 127, 193, 266, 299 💬
1031Probiotic - VSL#3----2件: 96, 97 💬
1032Probiotic capsule----1件: 6 💬
1033Probiotic capsules containing lactobacillus rhamnosus GR-1 and L. reuteri RC-14----1件: 46 💬
1034Probiotic formula capsule----1件: 97 💬
1035Probiotic group----1件: 271 💬
1036Probiotic K10----1件: 6 💬
1037Probiotic mixture----2件: 96, 97 💬
1038Probiotic product - CAP----1件: 53 💬
1039Probiotic supplement----1件: 6 💬
1040Probiotic throat spray----1件: 299 💬
1041Probiotic treatment----1件: 294 💬
1042Probiotic-lactobacillus plantarum PS128----1件: 156 💬
1043Probiotics----6件: 6, 94, 96, 97, 206, 291 💬
1044Probiotics combined with enteric-coated budesonide capsule1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 66 💬
1045Probiotics including B. lactis B420, B. lactis HN019, B. animalis BB-12, L. rhamnosus GG----1件: 193 💬
1046Probiotics with prebiotic----1件: 6 💬
1047Probucol1件: Probucol1件: Probucol 💬 --3件: 21, 66, 79 💬
1048Procalcitonin1件: Procalcitonin---1件: 299 💬
1049Procalcitonin-variants elisa-assay1件: Procalcitonin---2件: 43, 44 💬
1050Procaptan - 10 MG compresse rivestite CON film 60 compresse IN contenitore PER compresse PP----1件: 58 💬
1051Procaptan - 5 MG compresse rivestite CON film 10 compresse IN contenitore PER compresse PP----1件: 58 💬
1052Procedure/surgery: implant procedure----1件: 13 💬
1053Prochymal adult human mesenchymal stem cells1件: Remestemcel-L1件: Remestemcel-L 💬 --1件: 96 💬
1054Prochymal™ adult human mesenchymal stem cells1件: Remestemcel-L1件: Remestemcel-L 💬 --1件: 96 💬
1055Procysbi1件: Cysteamine3件: Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬 		--1件: 19 💬
1056Prodarsan----1件: 192 💬
1057Products containing aminosalicylate----1件: 97 💬
1058Products containing azathioprine or 6-mercaptopurine1件: Azathioprine2件: Azathioprine ,
Azathioprine sodium 💬 		--1件: 97 💬
1059Profilassi PER herpes zoster----1件: 107 💬
1060Progerinin1件: Progerinin1件: Progerinin 💬 --2件: 191, 333 💬
1061Progesterone1件: Progesterone1件: Progesterone 💬 1件: PGR 💬 5件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬2件: 76, 299 💬
1062Proglumide1件: Proglumide1件: Proglumide 💬 1件: CCKBR 💬 4件: Calcium signaling pathway, Gastric acid secretion, Hormone signaling, Neuroactive ligand-receptor interaction 💬1件: 298 💬
1063Prograf1件: Tacrolimus2件: Tacrolimus ,
Tacrolimus 💬 		5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬3件: 60, 222, 226 💬
1064Prograft capsules----1件: 299 💬
1065Progressive exercise----1件: 13 💬
1066Progressive resisted exercise training----1件: 49 💬
1067Progressive spacing OF TNF-blocker injections----1件: 46 💬
1068Progynova 21 mite----1件: 65 💬
1069Prolastin----1件: 231 💬
1070Prolastin-C1件: Alpha-1-proteinase inhibitor1件: alpha 1-Antitrypsin 💬 1件: SERPINA1 💬 1件: Complement and coagulation cascades 💬2件: 231, 298 💬
1071Prolastin-C, 120 MG/KG----1件: 231 💬
1072Prolastin-C, 60 MG/KG----1件: 231 💬
1073Proleukin1件: Aldesleukin1件: Aldesleukin 💬 3件: IL2RA,
IL2RB,
IL2RG 💬 		14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬2件: 2, 49 💬
1074Proleukin 18 MUI----1件: 2 💬
1075Proleukin® S1件: Aldesleukin1件: Aldesleukin 💬 3件: IL2RA,
IL2RB,
IL2RG 💬 		14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬1件: 65 💬
1076Prolia1件: Denosumab1件: Denosumab 💬 1件: TNFSF11 💬 8件: Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬1件: 274 💬
1077Prolife----1件: 97 💬
1078Proline1件: Proline1件: Proline 💬 --1件: 66 💬
1079Prolonged release tablet----1件: 6 💬
1080Prolonged-release fampridine----1件: 13 💬
1081Prolotherapy solution OF 20% dextrose----1件: 70 💬
1082Promacta----1件: 65 💬
1083Promethazine1件: Promethazine3件: Promethazine hydrochloride ,
Promethazine ,
Promethazine teoclate 💬 		1件: HRH1 💬 4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬2件: 6, 96 💬
1084Promethera hepastem----1件: 251 💬
1085Promiten----1件: 97 💬
1086Promixin----1件: 299 💬
1087Promixin 1 million international units (IU) powder FOR nebuliser solution----1件: 299 💬
1088Promixin*nebul 30monod 1MUI----1件: 299 💬
1089Promixin, 1 million international units (IU) powder FOR nebuliser solution----1件: 299 💬
1090Promixin,1 millóN DE unidades internacionales,polvo para solucióN para inhalacióN POR nebulizador----1件: 299 💬
1091Promixin/tadim----1件: 299 💬
1092Propanoic acid1件: Propanoic acid3件: Propionic acid ,
Sodium propionate ,
Sodium propionate 💬 		--2件: 6, 271 💬
1093Propanolol1件: Propranolol2件: Propranolol hydrochloride ,
Propranolol 💬 		3件: ADRB1,
ADRB2,
ADRB3 💬 		14件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 296 💬
1094Propantheline bromide1件: Propantheline1件: Propantheline bromide 💬 5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬 		14件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 26 💬
1095Propensity score----1件: 13 💬
1096Prophylactic corticosteroid taper regimen----1件: 251 💬
1097Prophylactic immunomodulatory (IM) therapy----1件: 19 💬
1098Prophylactic oral antibiotics: compound sulfamethoxazole tablet (SMZ/TMP) + cefaclor----1件: 296 💬
1099Propionate1件: Propionate ion---1件: 97 💬
1100Propionic acid 1000 MG capsule1件: Propanoic acid3件: Propionic acid ,
Sodium propionate ,
Sodium propionate 💬 		--1件: 13 💬
1101Propionyl L-carnitine1件: Levocarnitine2件: Levocarnitine chloride ,
Levocarnitine 💬 		--1件: 97 💬
1102Propionyl L-carnitine hydrochloride1件: Levocarnitine2件: Levocarnitine chloride ,
Levocarnitine 💬 		--1件: 97 💬
1103Propionyl-L-carnitine2件: Levocarnitine,
Levocarnitine propionate		3件: Levocarnitine chloride ,
Levocarnitine ,
Levocarnitine propionate hydrochloride 💬 		--1件: 97 💬
1104Propionylcarnitinhydrochlorid----1件: 97 💬
1105Propiverine hydrochloride1件: Propiverine2件: Propiverine hydrochloride ,
Propiverine 💬 		9件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S,
CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬 		44件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Regulation of actin cytoskeleton, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
1106Propofol1件: Propofol1件: Propofol 💬 16件: GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRB,
GABRB,
GABRB,
GABRD,
GABRE,
GABRG,
GABRG,
GABRG,
GABRP,
GABRQ 💬 		8件: GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬10件: 3, 6, 21, 22, 34, 46, 70, 97, 98, 296 💬
1107Propofol B. braun1件: Propofol1件: Propofol 💬 16件: GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRB,
GABRB,
GABRB,
GABRD,
GABRE,
GABRG,
GABRG,
GABRG,
GABRP,
GABRQ 💬 		8件: GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 97 💬
1108Propofol injection1件: Propofol1件: Propofol 💬 16件: GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRB,
GABRB,
GABRB,
GABRD,
GABRE,
GABRG,
GABRG,
GABRG,
GABRP,
GABRQ 💬 		8件: GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 70 💬
1109Propofol-lipuro1件: Propofol1件: Propofol 💬 16件: GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRB,
GABRB,
GABRB,
GABRD,
GABRE,
GABRG,
GABRG,
GABRG,
GABRP,
GABRQ 💬 		8件: GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 6 💬
1110Propolipid----1件: 46 💬
1111Proposed INN - filgotinib----1件: 46 💬
1112Propranolol1件: Propranolol2件: Propranolol hydrochloride ,
Propranolol 💬 		3件: ADRB1,
ADRB2,
ADRB3 💬 		14件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 158, 278 💬
1113Propranolol HCL CF 40 MG tablet1件: Propranolol2件: Propranolol hydrochloride ,
Propranolol 💬 		3件: ADRB1,
ADRB2,
ADRB3 💬 		14件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
1114Propranolol hydrochloride1件: Propranolol2件: Propranolol hydrochloride ,
Propranolol 💬 		3件: ADRB1,
ADRB2,
ADRB3 💬 		14件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 215, 216 💬
1115Propranolol treatment1件: Propranolol2件: Propranolol hydrochloride ,
Propranolol 💬 		3件: ADRB1,
ADRB2,
ADRB3 💬 		14件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 227 💬
1116Propsoed INN - filgotinib----1件: 46 💬
1117Propylene glycol-free melphalan hydrochloride1件: Propylene glycol2件: Propylene glycol ,
Propylene glycol diacetate 💬 		--1件: 28 💬
1118Prosavin----1件: 6 💬
1119Proscar*30CPR RIV 5MG1件: Finasteride1件: Finasteride 💬 1件: SRD5A2 💬 2件: Prostate cancer, Steroid hormone biosynthesis 💬1件: 6 💬
1120Prosetin1件: Prosetin---1件: 2 💬
1121Prospective observational registry----1件: 3 💬
1122Prostacyclin1件: Epoprostenol2件: Epoprostenol ,
Epoprostenol sodium 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
1123Prostacyclin receptor agonist1件: Epoprostenol2件: Epoprostenol ,
Epoprostenol sodium 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
1124Prostanoids----1件: 51 💬
1125Protandim----1件: 2 💬
1126Proteasa----1件: 299 💬
1127Protease----1件: 299 💬
1128Protease inhibitor----1件: 265 💬
1129Protease inhibitors----1件: 265 💬
1130Protectis----1件: 66 💬
1131Protein----2件: 46, 67 💬
1132Protein A immunoadsorption----1件: 13 💬
1133Protein and calorie controlled diet----1件: 251 💬
1134Protein expression analysis----2件: 28, 60 💬
1135Protein hydrolysate1件: Protein hydrolysate1件: Protein hydrolysate 💬 --1件: 97 💬
1136Protein intake----1件: 240 💬
1137Protein-carbohydrate supplementation----1件: 113 💬
1138Proteolytic enzyme fortified protein supplement----1件: 298 💬
1139ProteíNA recombinante estimulante DE LA megacariopoyesis----1件: 63 💬
1140Prothrombin complex concentrate2件: Factor IX Complex (Human),
Prothrombin		1件: Factor IX complex 💬 --1件: 288 💬
1141Prothrombin fragment 1+21件: Prothrombin---1件: 35 💬
1142Proton pump inhibitor 1 MG/KG/DAY IN 2 divided doses 1 month----1件: 63 💬
1143Prototype capsule GDC-0134----1件: 2 💬
1144Provigil1件: Modafinil1件: Modafinil 💬 --1件: 13 💬
1145Provigil - 100 MG compresse 30 compresse----1件: 113 💬
1146Proximod----1件: 46 💬
1147Prozac----1件: 17 💬
1148PRP----2件: 90, 226 💬
1149PRP and PBD-vsel stem cell therapy----1件: 6 💬
1150PRP combined magnovision----1件: 90 💬
1151PRP injection----1件: 53 💬
1152PRTX-1001件: PRTX-100---2件: 46, 63 💬
1153PRTX-100 AT 1.5 MCG/KG1件: PRTX-100---1件: 46 💬
1154PRTX-100 AT 12.0 MCG/KG1件: PRTX-100---1件: 46 💬
1155PRTX-100 AT 240 MCG1件: PRTX-100---1件: 46 💬
1156PRTX-100 AT 3.0 MCG/KG1件: PRTX-100---1件: 46 💬
1157PRTX-100 AT 420 MCG1件: PRTX-100---1件: 46 💬
1158PRTX-100 AT 6.0 MCG/KG1件: PRTX-100---1件: 46 💬
1159PRU-PLA-PLA-PRU----1件: 99 💬
1160PRU-PLA-PRU-PLA----1件: 99 💬
1161Prucalopride1件: Prucalopride2件: Prucalopride ,
Prucalopride succinate 💬 		1件: HTR4 💬 5件: Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway 💬2件: 13, 96 💬
1162Prucalopride succinate1件: Prucalopride2件: Prucalopride ,
Prucalopride succinate 💬 		1件: HTR4 💬 5件: Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway 💬1件: 51 💬
1163PRV-300----1件: 97 💬
1164PRV-3279----1件: 49 💬
1165PRV-6527----1件: 96 💬
1166PRX-102----1件: 19 💬
1167PRX-102 1 MG/KG every 2 weeks----1件: 19 💬
1168PRX-102 1 MG/KG every TWO weeks----1件: 19 💬
1169PRX-102 2 MG/KG every 4 weeks----1件: 19 💬
1170PRX-112----1件: 19 💬
1171PRX002----1件: 6 💬
1172PRX002, ELT2, ANTI-alpha-synuclein monoclonal antibody----1件: 6 💬
1173PRX102----1件: 19 💬
1174PS128----1件: 6 💬
1175PS188----1件: 113 💬
1176PS220----1件: 113 💬
1177PS524----1件: 113 💬
1178PS659----1件: 8 💬
1179Psaer IGY----1件: 299 💬
1180Pseudoephedrine1件: Pseudoephedrine3件: Pseudoephedrine hydrochloride ,
Pseudoephedrine sulfate ,
Pseudoephedrine 💬 		9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬 		16件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 17 💬
1181Pseudoephedrine + 480 ML water2件: Pseudoephedrine,
Water		4件: Water ,
Pseudoephedrine hydrochloride ,
Pseudoephedrine sulfate ,
Pseudoephedrine 💬 		9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬 		16件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 17 💬
1182Pseudoephedrine + 50 ML water2件: Pseudoephedrine,
Water		4件: Water ,
Pseudoephedrine hydrochloride ,
Pseudoephedrine sulfate ,
Pseudoephedrine 💬 		9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬 		16件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 17 💬
1183Psilocybin1件: Psilocybin1件: Psilocybin 💬 1件: HTR2 💬 6件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬2件: 2, 6 💬
1184Psilocybin therapy1件: Psilocybin1件: Psilocybin 💬 1件: HTR2 💬 6件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬3件: 2, 6, 13 💬
1185Psilocybin, 1.5 MG1件: Psilocybin1件: Psilocybin 💬 1件: HTR2 💬 6件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬1件: 206 💬
1186Psilocybine1件: Psilocybin1件: Psilocybin 💬 1件: HTR2 💬 6件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬1件: 6 💬
1187Psorcutan-ointment----1件: 36 💬
1188PSP----1件: 13 💬
1189PSRS11.EFS.IL2RG.PRE* retroviral vector----1件: 65 💬
1190Psychosocial intervention----1件: 6 💬
1191Psyllium1件: Plantago seed2件: Plantago seed ,
Psyllium husk 💬 		--2件: 6, 28 💬
1192Psyllium husk powder1件: Plantago seed2件: Plantago seed ,
Psyllium husk 💬 		--1件: 97 💬
1193Psyllium husks1件: Plantago seed2件: Plantago seed ,
Psyllium husk 💬 		--1件: 46 💬
1194PT320 2.0 MG----1件: 6 💬
1195PT320 2.5 MG----1件: 6 💬
1196PTC-0161480----2件: 246, 299 💬
1197PTC-124----2件: 246, 299 💬
1198PTC-C124----2件: 246, 299 💬
1199PTC0161480, PTC124 compound 1A, RPS2505, PTC-C124, 291844----1件: 113 💬
1200PTC124----4件: 19, 113, 246, 299 💬
1201PTC2991件: PTC299---1件: 34 💬
1202PTC518----1件: 8 💬
1203PTC518 tablet 20 MG----1件: 8 💬
1204PTC518 tablet 5 MG----1件: 8 💬
1205PTC743----2件: 18, 21 💬
1206PTC857----1件: 2 💬
1207PTC857 60 MG/ML oral solution----1件: 2 💬
1208PTC857 oral solution----1件: 2 💬
1209PTC923----1件: 240 💬
1210Pterostilbene1件: Pterostilbene---1件: 2 💬
1211PTG-100----1件: 97 💬
1212PTG-200----1件: 96 💬
1213PTH----1件: 235 💬
1214PTH 1-341件: Teriparatide3件: Teriparatide acetate ,
Teriparatide ,
Teriparatide acetate 💬 		1件: PTH1R 💬 4件: Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬2件: 65, 235 💬
1215PTH based calcium carbonate and calcitriol repletion----1件: 235 💬
1216PTH1-84 IN parent study----1件: 235 💬
1217PTI-428----1件: 299 💬
1218PTI-8011件: PTI-801---1件: 299 💬
1219PTI-808----1件: 299 💬
1220PTL201----1件: 13 💬
1221PTR-011件: PTR-01---1件: 36 💬
1222PTW-002 10 MG/G GEL1件: QR-313---1件: 36 💬
1223PTX-022----1件: 278 💬
1224PU-AD----1件: 2 💬
1225Puerarin injection 400 MG1件: Puerarin---1件: 46 💬
1226Puerarin tablet 50 MG1件: Puerarin---1件: 46 💬
1227Pulmonary endarterectomy----1件: 88 💬
1228Pulmonary endarteriectomy----1件: 88 💬
1229Pulmonary function test----1件: 51 💬
1230Pulmonary function testing----5件: 2, 228, 231, 299, 340 💬
1231Pulmonary hypertension (PH)-specific medication----1件: 88 💬
1232Pulmonary microbiome probiotic----1件: 294 💬
1233Pulmonary rehabilitation program----1件: 85 💬
1234Pulmozyme1件: Dornase alfa1件: Dornase alfa 💬 --1件: 299 💬
1235Pulmozyme single USE ampule----1件: 299 💬
1236PUR 0110----1件: 97 💬
1237PUR 0110 rectal enema----1件: 97 💬
1238PUR 0110 rectal enema 1000 MG----1件: 97 💬
1239PUR 0110 rectal enema 250 MG----1件: 97 💬
1240PUR 0110 rectal enema 500 MG----1件: 97 💬
1241PUR118----1件: 299 💬
1242Pure give pectin 20G/D FOR five days----1件: 97 💬
1243Puri nethol----2件: 96, 97 💬
1244PURI-nethol----3件: 86, 96, 97 💬
1245PURI-nethol 50 MG----1件: 96 💬
1246Purified form OF THE lysosomal enzyme iduronate-2-sulfatase----1件: 19 💬
1247Purinethol1件: Mercaptopurine2件: Mercaptopurine ,
Mercaptopurine 💬 		1件: hprT 💬 2件: Drug metabolism - other enzymes, Purine metabolism 💬1件: 96 💬
1248Purinethol - 50 MG compresse25 compresse----1件: 96 💬
1249PVT201----1件: 93 💬
1250PXL065----1件: 20 💬
1251PXL770----1件: 20 💬
1252PXT002331----1件: 6 💬
1253PXT002331 - 20MG----1件: 6 💬
1254PXT002331 - dose 1----1件: 6 💬
1255PXT002331 - dose 2----1件: 6 💬
1256PXT3003----1件: 10 💬
1257PXT3003 dose 1----1件: 10 💬
1258PXT3003 dose 2----1件: 10 💬
1259PXT3003 high dose----1件: 10 💬
1260PXT3003 intermediate dose----1件: 10 💬
1261PXT3003 LOW dose----1件: 10 💬
1262PYC-003----1件: 67 💬
1263PYM50028----1件: 6 💬
1264Pyrazole1件: Pyrazole---1件: 58 💬
1265Pyridin1件: Fenvalerate1件: Fenvalerate 💬 --1件: 75 💬
1266Pyridostigmine1件: Pyridostigmine1件: Pyridostigmine bromide 💬 1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬3件: 3, 11, 51 💬
1267Pyridostigmine bromide1件: Pyridostigmine1件: Pyridostigmine bromide 💬 1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬5件: 3, 6, 11, 51, 256 💬
1268Pyridostigmine, prednisone, tacrolimus1件: Pyridostigmine1件: Pyridostigmine bromide 💬 1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬1件: 11 💬
1269Pyridostigmine, tacrolimus1件: Pyridostigmine1件: Pyridostigmine bromide 💬 1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬1件: 11 💬
1270Pyridoxine1件: Pyridoxine2件: Pyridoxine hydrochloride ,
Pyridoxine 💬 		--1件: 320 💬
1271Pyridoxine 10MG BP1件: Pyridoxine2件: Pyridoxine hydrochloride ,
Pyridoxine 💬 		--1件: 93 💬
1272Pyridoxine phosphate2件: Pyridoxine,
Pyridoxine phosphate		2件: Pyridoxine hydrochloride ,
Pyridoxine 💬 		--1件: 234 💬
1273Pyridoxine plus prednisolone2件: Prednisolone,
Pyridoxine		3件: Prednisolone ,
Pyridoxine hydrochloride ,
Pyridoxine 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 145 💬
1274Pyrimethamine1件: Pyrimethamine1件: Pyrimethamine 💬 --4件: 2, 4, 19, 65 💬
1275Pyrophosphate----1件: 51 💬
1276Pyrrolidine1件: Pyrrolidine---1件: 28 💬
1277Pyrrolidone1件: Pyrrolidone---1件: 28 💬
1278Pyruvate, creatine, niacinamide----1件: 5 💬
1279Pyvst----1件: 25 💬